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ABSTRACT 
Streptococcus pneumoniae, pneumococcus, is an important human pathogen that causes both seri-
ous invasive infections, such as septicaemia, meningitis and pneumonia, as well as mild upper 
respiratory infections. It also belongs to the normal nasopharyngeal microbial flora. The purpose 
of this study was to compare bacteriological phenotypic methods with genetechnological methods
in the identification of pneumococci, especially among suspect pneumococcal isolates lacking one 
or more typical characteristics. In addition, we evaluated the usefulness of an STGG medium for 
the transport and storage of nasopharyngeal specimens and nasopharyngeal bacterial isolates.  
α-hemolytic streptococcal isolates identified as pneumococcus and isolates suspected to be pneu-
mococci were used in the comparisons of identification methods. S. pneumoniae, Haemophilus 
influenzae and Moraxella catarrhalis were used to test the survival of these bacteria in the STGG 
medium. Several phenotypic (optochin sensitivity, bile solubility, capsular quellung reaction) and 
genetechnological (a PCR based on virulence genes ply, psaA and lytA; a real-time ply PCR com-
bined with melting curve analysis; AccuProbe¥ and ARDRA) methods were used. A bacterial 
culture was used to detect bacteria in the STGG medium. 
A typical S. pneumoniae isolate is an optochin-sensitive, capsulated or unencapsulated, bile-
soluble α-hemolytic streptococcus. An optochin sensitivity test is a basic method for identifying 
pneumococcus, even from nasopharyngeal specimens. Genetechnological methods based on sev-
eral pneumococcal virulence genes provide new possibilities for identifying S. pneumoniae, but 
their use may lead to misidentification of some α-hemolytic streptococci as pneumococcus. In the 
present study, a real-time ply PCR confirmed by melting curve analysis of amplification products 
could exclude false positive ply PCR results. The STGG medium was confirmed to be a suitable 
medium for deep-freeze storage and transport of nasopharyngeal specimens and isolates of S.
pneumoniae, H. influenzae and M. catarrhalis.
In conclusion, an optochin sensitivity test is still the principal method for differentiating pneumo-
coccus from other α-hemolytic streptococci. The presence of pneumococcus-like bacteria compli-
cates identification. Differentiation between pneumococcus and suspected pneumococcal isolates 
was found to be problematic also when using genetechnological methods. A real-time ply PCR
combined with melting curve analysis of amplification products differentiates pneumococcus from 
other α-hemolytic streptococci. The definition of S. pneumoniae and the search for a method to use 
as a “gold standard” for pneumococcal identification are under abundant research. 
Keywords: Streptococcus pneumoniae, pneumococcus, identification, optochin sensitivity, real-
time ply PCR combined with melting curve analysis, STGG medium 
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TIIVISTELMÄ 
Streptococcus pneumoniae, pneumokokki, aiheuttaa sekä vakavia invasiivisia infektioita kuten 
sepsistä (”verenmyrkytys”), aivokalvontulehdusta ja keuhkokuumetta että lieviä ylähengitysteiden 
tulehduksia. Pneumokokki kuuluu myös nenänielun normaaliin bakteerikasvustoon. Tässä tutki-
muksessa verrattiin pneumokokin ilmiasuun perustuvia tunnistusmenetelmiä geeniteknologisiin 
menetelmiin. Lisäksi arvioitiin, soveltuuko STGG elatusaine nenänielunäytteiden ja niistä eristet-
tyjen bakteerien kuljettamiseen ja säilyttämiseen. 
Tutkimusaineisto koostui pneumokokiksi tunnistetuista ja pneumokokiksi epäillyistä (bakteerilta 
puuttuu yksi tai useampi pneumokokille tyypillisistä ominaisuuksista) α-hemolyyttisistä strepto-
kokkikannoista.  S. pneumoniae, Haemophilus influenzae ja Moraxella catarrhalis kantoja käytet-
tiin tutkittaessa ko. bakteerien säilymistä STGG elatusaineessa. Tutkimuksessa käytettiin useita 
erilaisia bakteerin ilmiasuun perustuvia (optokiiniherkkyys, sappiliukoisuus, kapselin turpoami-
nen) sekä geeniteknologisia (virulenssigeenejä ply, psaA ja lytA osoittavat PCR-menetelmät, reaa-
li-aikainen ply PCR yhdistettynä sulamiskäyräanalyysiin, AccuProbe¥ ja ARDRA) tunnistusme-
netelmiä. Bakteerit osoitettiin STGG elatusaineesta bakteeriviljelyllä. 
Tyypillinen pneumokokki on optokiinille herkkä, kapselillinen tai kapseliton, sappeen liukeneva 
α-hemolyyttinen streptokokki. Pneumokokki tunnistetaan useimmiten luotettavasti optokiiniherk-
kyystestillä. Molekyylimikrobiologiset menetelmät, jotka perustuvat pneumokokin virulenssigee-
nien osoittamiseen, tarjoavat uusia mahdollisuuksia tunnistamiseen. Muutkin α-hemolyyttiset 
streptokokit voivat siepata pneumokokin virulenssigeenejä, ja tämä voi johtaa näiden α-
hemolyyttisten streptokokkien väärään tunnistamiseen pneumokokeiksi. Omien tutkimustemme 
mukaan α-hemolyyttisten streptokokkien ja pneumokokin ply geenit poikkeavat toisistaan ja vää-
rät positiiviset ply PCR tulokset voitiin sulkea pois reaaliaikaisella ply PCR-menetelmällä yhdistet-
tynä monistustuotteiden sulamiskäyräanalyysiin, jolla osoitettiin ply geenin mutaatiot. STGG ela-
tusaine soveltui hyvin nenänielunäytteiden ja S. pneumoniae, H. influenzae ja M. catarrhalis kan-
tojen kuljettamiseen ja säilyttämiseen.  
Yhteenvetona voidaan todeta, että optokiinitesti on edelleen perusmenetelmä, jolla pneumokokki 
erotetaan muista α-hemolyyttisistä streptokokeista. Pneumokokkia läheisesti muistuttavien bak-
teerien tunnistaminen ja niiden erottaminen pneumokokista oli ongelmallista myös geeniteknolo-
gisilla menetelmillä. Reaaliaikainen ply PCR monistustuotteiden sulamiskäyräanalyyseineen erotti 
pneumokokin muista α-hemolyyttisistä streptokokeista. Pneumokokin määritelmä ja pneumokokin 
tunnistuksen “kultaisena standardina” toimivan menetelmän etsintä ovat edelleen tärkeitä tutki-
muskohteita. 
Avainsanat: Streptococcus pneumoniae, pneumokokki, tunnistaminen, optokiiniherkkyys, reaaliai-
kainen ply PCR yhdistettynä monistustuotteiden sulamiskäyräanalyysiin, STGG elatusaine  
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1 INTRODUCTION
Streptococcus pneumoniae, pneumococcus, is an important pathogen that causes both 
serious invasive infections, such as septicaemia, meningitis and pneumonia, and mild 
upper respiratory infections. It belongs to the normal nasopharyngeal microbial flora that 
consists of bacteria with physiologic and genetic properties suitable for colonization and 
multiplication under certain conditions. These microbes are usually harmless and they 
even benefit human health by preventing the growth of more pathogenic bacteria. 
Pneumococcus was described the first time over 130 years ago. In spite of the develop-
ment of new possibilities to examine pneumococcus, the traditional phenotypic definition 
of S. pneumoniae has not changed. Pneumococcus is a gram-positive, α-hemolytic, bile-
soluble and commonly capsulated streptococcus that is usually identified without prob-
lems. Identification is based on the bacterial colony morphology on a blood agar plate, 
optochin sensitivity, bile solubility and the presence of a capsule. So far, 90 different 
capsular serotypes have been identified (see White 1938, Kauffman et al. 1940, Mørch 
1943, Lund 1970, Lund et al. 1972, Austrian et al. 1985, Henrichsen 1995). In addition, 
unencapsulated isolates are rather common in the nasopharynx (Finland & Barnes 1977, 
Carvalho et al. 2003). 
S. pneumoniae belongs to the bacterial species that develop natural competence via trans-
formation (Lorenz & Wackernagel 1994), which is an important mechanism allowing 
pneumococcus to adapt to environmental changes. Commensal species, especially other 
α-hemolytic streptococci, have a major role in the evolution of S. pneumoniae, and ex-
changes of virulence factors such as pneumolysin and autolysin occur among streptococ-
cal species (Whatmore et al. 2000, Jado et al. 2001). Molecular taxonomic studies have 
increased information on bacterial relationships, and during the last decades have brought 
changes to the classification of the genus Streptococcus (van Belkum et al. 2001, Fack-
lam 2002). 
Identification of suspected pneumococcal isolates lacking one or more of the typical char-
acteristics was found to be problematic in the National Reference Laboratory for Pneu-
mococcus (National Public Health Institute, Oulu) that receives streptococcal isolates 
suspected of being pneumococci for confirmation of identification and serotyping. More 
specifically, the occurrence of optochin-resistant pneumococcal isolates (Kontiainen & 
Sivonen 1987, Pikis et al. 2001) and unencapsulated pneumococci, especially in the na-
sopharynx, creates a need to compare phenotypic identification methods with methods 
based on gene technology and to develop new identification methods. In addition, to ana-
lyze the clonal spread of bacteria during epidemics and to identify antibiotic-resistant or 
otherwise virulent clones, molecular typing methods are needed to characterize bacterial 
pathogens such as pneumococcus below the species level. 
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2 REVIEW OF THE LITERATURE 
2.1 Streptococcus pneumoniae 
2.1.1 Pneumococcal infections and epidemiology, treatment and prevention 
Infections caused by S. pneumoniae can be divided into two categories. In invasive infec-
tions (e.g. meningitis, pneumonia and bacteraemia), pneumococcus can be isolated from 
blood or other normally sterile body fluids. In mucosal infections such as sinusitis, otitis 
media and conjunctivitis, pneumococcus can be isolated from mucosal excretions only 
(Musher 1992, Feldman & Klugman 1997, Bogaert et al. 2004). 
The spectrum of pneumococcal diseases differs in different age groups and different popu-
lations (Musher 1992, O'Brien & Santosham 2004, Bogaert et al. 2004, Hausdorff et al.
2005). Several risk factors for pneumococcal infection, such as age, race, immunodefi-
ciency, other illness, socio-economic status, previous antibiotic therapy and day-care atten-
dance have been reported (O'Brien & Santosham 2004). Pneumococcus is a leading patho-
gen, causing infections with high mortality and morbidity (Austrian 1977, Scott et al. 1996, 
Hausdorff et al. 2000a, Hausdorff et al. 2000b, O'Brien & Santosham 2004). At least one 
million children die annually from pneumococcal diseases, and most of them are young 
children in developing countries (WHO 1999, Williams et al. 2002). Invasive pneumococ-
cal infections also occur in industrialized countries, especially among children and elderly 
people (Eskola et al. 1992, Scott et al. 1996, Sankilampi et al. 1997, Hausdorff et al. 2005). 
In Finland, S. pneumoniae was among the six most common microbes isolated from inva-
sive infections in all age groups during 1995-2004 (Kansanterveyslaitos 2005). 
Acute otitis media (AOM) is one of the most frequent diagnoses in children under 15 
years of age in the United States (Schappert 1992, Berman 1995, O'Brien & Santosham 
2004). In Finland, the estimated number of otitis media episodes among Finnish children 
has increased from 200,000 per year in 1982 to 500,000 per year in 1997 (Kontiokari 
1998). S. pneumoniae is the most common pathogen isolated from middle ear fluid in 
patients with AOM (Luotonen et al. 1981, Bluestone et al. 1992, Kilpi et al. 2001). 
Quinine and its derivate, ethylhydrocupreine, was found to protect mice against pneumococ-
cal infection, but unfortunately in therapeutic doses it was toxic to humans (see White 1938). 
Serum therapy used in the 1920s to treat pneumococcal infection was replaced by sulfona-
mides in the 1930s and later by penicillin and other antibiotics (Watson et al. 1993). Wide 
antibiotic use has led to the appearance of multidrug resistant pneumococcal isolates and dif-
ficulties in treating pneumococcal infections. In the United States, approximately 24 % of 
isolates of invasive pneumococcal infections have been reported to be penicillin-
nonsusceptible (O'Brien & Santosham 2004). In Finland the corresponding number was 9.6 % 
in 2004, and multidrug resistance was 3.7 % (Kansanterveyslaitos 2005). 
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Pneumococcal vaccines have been developed to prevent pneumococcal infections. The 
first vaccination attempts were made among South African gold miners by using whole 
pneumococcal cells and later in young men by using capsular polysaccharides of types 1, 
2, 5 and 7. In 1977, 14-valent and in 1983, 23-valent polysaccharide vaccines were intro-
duced (Watson et al. 1993, WHO 1999, O'Brien & Santosham 2004). Unfortunately, 
polysaccharide vaccines were not immunogenic in young children, the elderly and im-
munocompromised patients, i.e. in people who are considered to be at a high risk for life-
threatening pneumococcal infection. Later, new second-generation vaccines, 7-, 9- and 
11-valent polysaccharide protein conjugate vaccines, have been developed (Klein & 
Eskola 1999, O'Brien & Santosham 2004, Peltola et al. 2004). These conjugate vaccines 
seem to work best in infants and high-risk groups (Klein & Eskola 1999, Whitney et al.
2003, O'Brien & Santosham 2004). According to Cutts and co-workers, pneumococcal 
conjugate vaccine is a valuable tool for preventing pneumonia, bacteraemia and mortality 
in African children (Cutts et al. 2005). Unfortunately, their effect against otitis media is 
limited (Eskola et al. 2001, O'Brien & Santosham 2004), and replacement into nonvac-
cine serotypes occurs (Dagan 2004, Bogaert et al. 2004). Next-generation vaccines, 
pneumococcal protein vaccines based on different pneumococcal virulence factors, such 
as pneumococcal surface protein A (PspA), pneumococcal surface antigen A (PsaA) and 
pneumolysin (Ply), are under development (Bogaert et al. 2004). 
2.1.2 History of pneumococcus 
The history of pneumococcus starts as early as 1875, when Klebs found nonmotile, some-
times linked “monads” when searching for the cause of pneumonia and examining fluids 
from the lungs of pneumonia patients with a microscope (reviewed by White 1938). This 
finding led to subsequent pneumococcal research during the following decades. In 1881, 
Sternberg in the USA and Pasteur in France independently inoculated rabbits with saliva 
and showed the pathogenicity of the organism (see Table 1). However, Pasteur was the 
first to report his finding, and he was also able to isolate the organism from infected rab-
bits by cultivation (see White 1938). 
After the discovery of pneumococcus, its name has changed several times. It was named 
Microbe septicemique du salive by Pasteur and Micrococcus pasteuri by Sternberg. After 
having the names Pneumococcus and Diplococcus pneumoniae, the organism was given 
its present name, Streptococcus pneumoniae, in 1974 according to its characteristic prop-
erty of growing as chains of cocci in a liquid media (Bergey et al. 1974). 
Austrian (Austrian 1981) states in his review “Pneumococcus: The First One Hundred 
Years”: “It is not possible within the time allotted to review all that is known of the biol-
ogy of the pneumococcus and of the diseases it causes in humans”. Pneumococcus has 
been involved in many historical findings concerning microbes, microbial pathogenesis 
and host defence. A new era in the research on pneumococcus started when the genome 
of pneumococcus was published (Hoskins et al. 2001, Tettelin et al. 2001). The most 
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significant findings related to identification of pneumococcus are summarized in Table 1. 
Two recently published handbooks, “The Pneumococcus” edited by Tuomanen, Mitchell, 
Morrison and Spratt (Tuomanen 2004) and “Streptococcus pneumoniae, Molecular Biol-
ogy and Mechanism of Disease” edited by Tomasz (Tomasz 2000), present detailed facts 
on pneumococcal research in excellent chapters. 
Table 1. History of the identification and characterization of pneumococcus.
Year Description of phenomenon Reference 
1875 Nonmotile,linked “monads” in fluid in lungs of 
pneumonia patients. 
Klebs (in White 1938) 
1880 Nonmotile,slightly oval, nearly round “bodies” oc-
curing singly but more often in pairs, considered as 
varieties of diphtheria or pyemia micrococci. 
Eberth (in White 1938) 
1880 Cocci found in sputum of pneumonia patients and 
in normal sputum, and named Pneumoniekokken.
Matray (in White 1938) 
1881 Rabbits inoculated with Sternberg’s saliva devel-
oped fatal septicemia. The first time pneumococcus 
was isolated through animal passage. 
Sternberg (in White 1938) 
1881 Rabbits inoculated with saliva of a child dead from 
rabies. “New virus”, when transferred from infected 
to normal rabbits, caused infections each time. 
Pasteur (in White 1938) 
1881 Lance-shaped diplococci found from pneumonic 
lung tissue. 
Koch (in White 1938) 
1882 In stain preparations of lung puncture, cocci sur-
rounded by an unstained rim. First observation of 
the capsule.
Günther (in White 1938) 
1883 Micrococci in alveolar exudate stained by Gram 
stain exhibited the well-defined capsule. After cul-
tivation on Koch`s coagulated blood serum, a col-
ony description  typical to pneumococcus. Coccus 
lost its capsule after several transfers and grew in 
“nail-form” colonies.  
Friedländer (in White 
1938) 
1884 “Indispensable stain”. Slightly elongated cocci with 
dark aniline-gentian violet (gram-positive) easier to 
find in lung tissues. 
Gram (in White 1938) 
1886 First complete description of pneumococcus and its 
etiological relationship with lobar pneumonia in 
humans. 
Fraenkel (in White 1938) 
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1892 Inoculated virulent, heated pneumococci induced 
low immunity in rabbits. Obtained rabbit serum 
mixed with pneumococcal growth had different 
appearance compared with normal serum: the phe-
nomenom is later called agglutination. 
Mosny (in White 1938) 
1897 Several “races” of pneumococci that behaved sero-
logically as different microbes. 
Bezançon and Griffon (in 
White 1938) 
1900 Bile dissolves the pneumococcal cell  Neufeld (in White 1938) 
1902 Specific reactions between pneumococcal antise-
rum and growth; macroscopic agglutination and 
microscopically visible, specific swelling of the 
capsule. Quellung reaction. 
Neufeld  (in White 1938) 
1910 Isolates classified into two groups, I and II, accord-
ing to protection of mice immunized with pneumo-
coccal type I or II. Recognition of the existence of 
several types and recommendations for developing 
serums for all types. Determination of infection 
type before serum therapy suggested.  
 Neufeld and Haendel (in 
White 1938) 
1911 Quinine and some of its derivates, especially opto-
chin, have bactericidal property. 
 Morgenroth and Levy (in 
White 1938) 
1913 Group I and II, group III consisted of organisms of 
Pneumococcus mucosus type, group IV is a hetero-
genous group. 
 Dochez and Gillespie (in 
White 1938) 
1923 Letters S and R given to two forms of colonies. S 
colonies have a smooth surface, being virulent for 
laboratory animals, and R colonies have a rough 
surface and are avirulent. 
Griffith (in White 1938)  
1929 Simple, rapid “Stained Slide” for microscopic ag-
glutination test. 
Sabin (in White 1938) 
1932 Separation of serotypes in group IV into 29 types. 
The total number of types was 30.  
Cooper et al. (in White 
1938)  
1933 Quellung reaction method for typing. Neufeld and Etinger-
Tulczynska (in White 
1938)  
1940 20 new serotypes were described. (Kauffman et al. 1940) 
1942 18 new serotypes described. The total number of 
serotypes is 68. 
(Mørch 1943) 
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1943 Optochin in low concentrations in blood agar inhib-
its pneumococcal growth. 
(Mørch 1943) 
1944 DNA (Avery et al. 1944) 
1954 Identification of pnemococcus by optochin sensitivity 
test. 
(Bowers & Jeffries 1955) 
1974 Pneumococcus was given its present name S.
pneumoniae.
(in Bergey et al. 1974) 
1978 The total number of serotypes is 83. (Lund 1970, Lund et al.
1972) 
1985 Serotype 16A (Austrian et al. 1985) 
1993 Identification of pneumococcus based on the ampli-
fication and detection of the pneumolysin gene 
(Rudolph et al. 1993) 
1995 6 new serotypes. The present number of serotypes  
is 90. 
(Henrichsen 1995) 
1999 Multilocus sequence typing (MLST) for pneumococci. (Spratt 1999) 
2001 Complete genome sequence of S. pneumoniae. (Tettelin et al. 2001, 
Hoskins et al. 2001) 
2006 Genetic analysis of the capsular biosynthetic locus 
of all 90 pneumococcal serotypes. 
(Bentley et al. 2006) 
2.1.3 Taxonomy of pneumococcus 
The bacterial taxonomy of pneumococcus was earlier based on a description of the pheno-
typic, physiological and biochemical characteristics of bacterial species. The genomic defi-
nition of bacterial species became possible when DNA-based methods were developed and 
bacterial species were arranged into a phylogenetic tree based on a comparison of rRNA 
sequences (van Belkum et al. 2001, Vandamme 2003). Species in the genus Streptococcus
have been classified in several ways over the years (Colman & Williams 1972, Facklam 
1977, Schleifer & Kilpperbalz 1987, Kilian et al. 1989, Coykendall 1989, Facklam 2002). 
Despite the progress that has been made in recent years towards a better understanding of 
the roots of bacterial origin, identification of the viridans group of streptococci and the spe-
cies within it has been problematic due to the close relationship and normal variation among 
strains. Genetic transformation (Lorenz & Wackernagel 1994, Fink 2005), exchanges of 
virulence factors among streptococcal species (Whatmore et al. 2000, Jado et al. 2001) and 
the appearance of new closely related streptococcal species, such as S. sinensis (Woo et al.
2002) and S. pseudopneumoniae (Arbique et al. 2004), confirm that problems in taxonomy 
and pneumococcal identification will continue in the future. 
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In the 1970s, the authorities Colman and Williams in the United Kingdom (UK) (Colman 
& Williams 1972) and Facklam in the United States (USA) (Facklam 1977) had a dis-
agreement concerning the grouping and nomenclature of viridans streptococci. In 1986 
Bergeys`s Manual of Systematic Bacteriology used the classification by Colman and Wil-
lison, but several commercial identification kits used the classification of Facklam 
(French et al. 1989). The next changes in the classification of streptococci were made 
after determining their phylogenetic relationship based on 16S rRNA sequences of the 
type strains of S. mitis and S. gordonnii among members of the genus Streptococcus. The 
genus Streptococcus was divided into the pyogenic and viridans groups, and the latter 
further into the anginosus group, the mitis group, the salivarius group, the bovis group 
and the mutans group, and into some separate species. S. mitis and S. gordonnii were 
clustered in the mitis group with S. pneumoniae, S. oralis, S. sanguis and S. parasanguis,
and their sequence homology level was more than 96 %. The sequence homology of the
S. mitis, S. oralis and S. pneumoniae group was more than 99 % with each other, although 
the DNA-DNA similarity values of their total chromosome DNAs were less than 60 % 
(Kawamura et al. 1995). The results of nucleic acid hybridization showed clearly that 
Streptococcus pneumoniae is a member of the oral streptococci and has a genetically 
close relationship with S. oralis (Schleifer & Kilpperbalz 1987).
The last decades have brought a lot of changes in the classification of the genus Strepto-
coccus, as molecular taxonomic studies have produced more data on bacterial relation-
ships (van Belkum et al. 2001, Facklam 2002). According to the Manual of Clinical Mi-
crobiology, 8th edition (Murray et al. 2003), pneumococcus is defined as follows: pneu-
mococcus belongs to the genus Streptococcus. Among non-beta-hemolytic streptococcal 
strains, alpha-hemolytic strains can be separated into the species S. pneumoniae and the 
viridans division, which is composed of a number of species groups. S. pneumoniae has a 
role as a normal inhabitant and as a human pathogen. S. pneumoniae is considered as a 
member of the mitis species group (Ruoff et al. 2003). Nowadays this classification 
seems to be used in most publications. 
2.1.4 Biology of pneumococcus 
Over 130 years since the first discovery of pneumo-
coccus, the traditional phenotypic definition of S. 
pneumoniae has not changed. In a Gram-stain, pneu-
mococcus appears as an oval-shaped, gram-positive 
coccus, 1-2 μm in diameter, typically in pairs, some-
times singly or in short chains (Fig. 1). The gram-
positive reaction of young cells may be lost when the 
culture is aged. Pneumococcus grows as α-hemolytic, 
centrally depressed colonies on blood agar, and gen-
erally upon primary isolation it is heavily encapsu-
Fig. 1. Gram-stained pneumococci 
from blood culture.
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lated. It is catalase-negative and facultatively anaerobic, but can grow aerobically (Bergey
et al. 1974). However, 8 % of clinical pneumococcal isolates require an enriched carbon 
dioxide (CO2 ) atmosphere if they are cultured on a solid medium (Austrian & Collins 
1966), and thus it is recommended that cultures be incubated in a CO2-enriched atmos-
phere. The nutritionally fastidious bacteria need blood or serum to grow, and they are 
unable to synthesize hemin. By the action of pyruvate oxidase (SpxB) under aerobic 
growth conditions, pneumococcus utilizes oxygen to form hydrogen peroxide. Hydrogen 
peroxide is toxic to cultured alveolar epithelial cells and other bacterial organisms of the 
upper respiratory tract, especially to H. influenzae (Pericone et al. 2000). Peroxide de-
stroys the labile constituents of the pneumococcal cell and thus, pneumococcus may de-
stroy itself. 
Streptococci, and thus also pneumococcus, belong to the heterotrophic bacterial species 
that uses organic compounds as a source of carbon, and their energy-yielding metabolism 
is fermentative, yielding low levels of lactid acid. Glucose and other carbohydrates are 
fermented. Production of the leucine aminopeptidase (LAP) enzyme is a typical charac-
teristic of all streptococci, whereas production of pyrrolidonyl arylamidase (PYR) is rare 
among streptococci, occurring only in S. pyogenes isolates and in some pneumococcal 
isolates (Ruoff et al. 2003). Published genome analysis suggests that S. pneumoniae has 
pathways for catabolism of pentitols as well as for cellobiose, fructose, fucose, galactose, 
galactitol, glucose, glycerol, lactose, mannitol, mannose, raffinose, sucrose, trehalose, and 
maltosaccharides. In addition, ten amino acids and N-acetylglucosamine can be used as 
nitrogen and carbon sources (Tettelin et al. 2001). 
So far, 90 different capsular serotypes have been identified 
(Henrichsen 1995), and they are grouped into 46 sero-
types/groups based on antigenic similarities. Colony mor-
phology may vary from small (e.g. unencapsulated) to 
clearly depressed and to very large and mucoid colonies, as 
in the case of serotypes 3 and 37. Colonies have been de-
scribed as mucoid, ruffled and smooth (see White 1938), or 
opaque and transparent (Weiser et al. 1994) (Fig. 2). Ap-
pearance is dependent on surface proteins, capsule and cell 
wall composition (Watson et al. 1993). In the phenomenon 
called phase variation, variants have the same serotype and 
are named as transparent or opaque forms of colonies. Opaque variants are larger and whit-
ish, whereas transparent colonies are smaller and bluish (Weiser et al. 1994). Opaque phe-
notypes have more capsular polysaccharide (Kim & Weiser 1998) and have been isolated 
commonly from blood (Weiser et al. 1994). Transparent colonies have more teichoic acid 
(Kim & Weiser 1998) and they are usually found in the nasopharynx (Weiser et al. 1994). 
Surprisingly, phase variation of the transparent phenotype increases invasion into human 
brain microvascular endothelial cells as much as six-fold, and this phenomenon might be 
important in the development of meningitis (Ring et al. 1998). In a comprehensive and 
Fig. 2. Opaque and transparent 
colonies on a blood agar plate.
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detailed review by van der Woude and Bäumler (van der Woude & Baumler 2004), the 
term phase variation in general means a reversible switch between on/off expressing phases, 
which results from variation in the level of expression of one or more proteins between 
individual cells of a clonal population.  
2.1.5 Pneumococcal genetic transformation  
Griffith found in 1928 that some heat-killed encapsulated (smooth form) pneumococci 
could transfer capsule production and mouse pathogenecity into unencapsulated (rough) 
strains (see White 1938). Later, a group at Rockefeller Institute studied the chemical 
composition of this “transforming principle”, and in 1944 Avery, McCarty and MacLeod 
reported that “ a nucleic acid of the deoxyribose type” (later named DNA) is the genetic 
material and is responsible for phenotypic changes during the transformation (Avery et al.
1944). Natural genetic transformation is a mechanism of horizontal gene transfer and 
depends on the function of several genes located on the bacterial chromosome. The ability 
to transform is mostly a transient and induced physiological property (Lorenz & Wacker-
nagel 1994). The transformation of pneumococci is a complicated process in which sev-
eral genes participate, and at least 28 genes are connected to the transformation of S.
pneumoniae (Lacks 2004). 
Natural competence transformation is an important mechanism allowing pneumococcus 
to adapt to changes in the environment. Commensal species, especially other α-hemolytic 
streptococci, have a major role in the evolution of S. pneumoniae. Exchanges of virulence 
factors among streptococcal species (Whatmore et al. 2000, Jado et al. 2001) as well as 
the appearance and spread of antibiotic resistance (Klugman 1990, Nissinen et al. 1995, 
Lister 1995, Whitney et al. 2000, Pihlajamäki et al. 2002) are well known. On the other 
hand, overestimation of penicillin resistance among nasopharyngeal pneumococcal iso-
lates (Wester et al. 2002) may be caused by differentiation problems between S. pneumo-
niae and other α-hemolytic streptococci (Mundy et al. 1998, Messmer et al. 2004). Peni-
cillin-binding protein (PBP) genes are responsible for the penicillin resistance of S.
pneumoniae (Ubukata et al. 1996, Overweg et al. 2001). The connection between PBP 
genes, mosaic blocks and transformation (Hakenbeck 2000) is an interesting finding. The 
connection between penicillin resistance and pneumococcal serotype has also been dem-
onstrated, and penicillin-resistant clones have been shown to switch their serotype 
(Coffey et al. 1991, Coffey et al. 1998). Since the capsular gene cluster is located imme-
diately adjacent to the PBP genes, resistance and the new serotype could be transferred at 
the same time. Hakenbeck convincingly presents (Hakenbeck 2000) that nearly identical 
sequences of mosaic blocks in PBP genes between genetically distinct clones of resistant 
pneumococci are signs of a common ancestor but different transformation. The same 
class of mosaic PBP genes can be found in resistant strains of related streptococcal spe-
cies, and penicillin-sensitive S. mitis and S. oralis strains have mosaic blocks that are 
highly related to the blocks of PBP genes of resistant S. pneumoniae (Hakenbeck 2000). 
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S. pneumoniae is able to express inter-strain heterogeneity, as the 90 different serotypes 
(Henrichsen 1995) and different phenotype variations (Weiser et al. 1994) demonstrate. 
Transparent variants, common among nasopharyngeal pneumococcal isolates (Kim & 
Weiser 1998), are transformed at 9-670 times higher rates than opaque variants and thus, 
genetic transformation selects a less-encapsulated subpopulation (Weiser & Kapoor 
1999). Recent analysis of the genome-sequenced isolates TIGR 4 (Tettelin et al. 2001) 
and R6 (Hoskins et al. 2001) has revealed several signs of gene transfer events, such as 
the occurrence of insertion sequences and transposable elements (Bruckner et al. 2004). 
In a comparison of pneumococcus with other transforming bacteria, homologs of the 
genes responsible for competence and DNA uptake have been found. These other species 
can be divided into four groups. Group I consists of closely related streptococcal species 
like S. mitis and S. gordonnii, and group II consists of more distantly related streptococcal 
species like S. mutans and S. pyogenes. Group III consists of bacterial species that are 
closely related to Streptococcus, but outside the genus Streptococcus, like Lactococcus 
lactis and Entereococcus faecalis. Group IV is formed from distantly related bacteria that 
are naturally transforming, among them H. influenzae and B. subtilis (Lacks 2004). 
2.1.6 The capsule and serotypes/groups 
Several human pathogenic bacteria, such as Haemophilus influenzae, Neisseria meningi-
tidis, Eschericia coli and S. pneumoniae, have a polysaccharide capsule that surrounds the 
bacterial cell. Pneumococci may occur in two forms, unencapsulated and capsulated. The 
capsule and the amount of produced capsules are significant virulence factors (Paton et al.
1993, Kim & Weiser 1998). The capsule protects bacterial cells very effectively from 
phagocytosis and also inhibits complement activation. The capsule also protects against 
environmental effects, and the produced components help pneumococci compete with 
other bacteria, such as H. influenzae, Moraxella catarrhalis and N. meningitidis, for exis-
tence in the nasopharynx (Pericone et al. 2000). 
Pneumococcal capsular polysaccharides are a diverse group of polyglycans that make the 
capsule acid (Jedrzejas 2004). These capsular polysaccharides are antigenic (Sørensen 1995) 
and they have the ability to induce specific antibodies (see White 1938, Austrian 1981). 
In 1910 only two separate types of pneumococci were detected by inoculation of the iso-
lates into previously immunized mice (see White 1938). In 1932 the number of identified 
serotypes/groups was 32 (see White 1938), and some fifty years later it was 84 (Lund & 
Henrichsen 1978, Austrian et al. 1985). In 1955 Henrichsen described (Henrichsen 1995) 
six new serotypes and thus, the number of serotypes is 90 today. The serotypes differ 
from each other by chemical differences in their capsular polysaccharides. Their ability to 
induce specific antibodies in rabbits is the basis for serotyping (Lund & Henrichsen 1978, 
Henrichsen 1999). 
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There are two different serotyping systems, namely the Danish (Kauffman et al. 1940, 
Lund 1970) and the American systems (Eddy 1944). The Danish system groups serotypes 
on the basis of antigenic similarities (for instance group 19 consists of 19F, 19A, 19B and 
19C), whereas in the American system the serotype numbers are in the order in which 
they have been described (19, 57, 58 and 59, respectively) (Broome & Facklam 1981, 
Musher 1992). The Danish nomenclature for serotyping has proved to be functional and is 
commonly used both in pneumococcal reference laboratories and in research (Hall 1998).  
Unencapsulated pneumococci are present in 0.5 % to 2 % of sterile site specimens 
(Broome & Facklam 1981, Carvalho et al. 2003), in 20 % of conjunctival specimens 
(Finland & Barnes 1977), and in up to 10 % of specimens obtained from nonsterile sites 
such as sputum, the oral pharynx or the nasopharynx (Carvalho et al. 2003). 
Among the 90 different polysaccharide serotypes (Henrichsen 1995), some are more viru-
lent than others. A small number of them, approximately 10 serotypes/groups, are com-
mon in pneumococcal infections (Scott et al. 1996, Hausdorff et al. 2000b, Hausdorff et 
al. 2000a, Hausdorff et al. 2005). According to a recent review, serotypes/groups 1, 3, 5, 
6, 14, 19 and 23 are comprehensive types in invasive pneumococcal infections on several 
continents (Hausdorff et al. 2005). In the United States, serotypes 4, 6B, 9V, 14, 18C, 
19F and 23F are commonly isolated from both invasive and middle-ear infections 
(O'Brien & Santosham 2004).  In Finland, the most common serotypes isolated from in-
vasive infections in 1995-2004 were 14, 4, 9V, 3, 23F and 7F, and in 2002-2004 these 
serotypes caused almost half of all invasive pneumococcal infections 
(Kansanterveyslaitos 2005). 
The serotypes/groups 6A, 6B, 14, 15, 18C, 19F and 23F are commonly isolated from the 
nasopharynx of healthy children on every continent (Bogaert et al. 2004). The sero-
types/groups 10, 11, 13, 15, 33 and 35 are also fairly common in the nasopharynx of 
healthy children (Bogaert et al. 2004, Hausdorff et al. 2005), whereas types 1, 5 and 46 
are rare even in populations where they are isolated from invasive infections (Hausdorff
et al. 2005). In Finland in 2001, the six most common serotypes isolated from naso-
pharyngeal specimens of healthy children under two years of age were 6B, 23F, 19F, 6A, 
11 and 14 (Syrjänen et al. 2001) and 19F, 23F, 6A, 6B, 14 and 11 were isolated from 
specimens of acute otitis media (AOM) (Kilpi et al. 2001). This type of distribution is 
quite similar to that in an earlier AOM study (serogroups/types 19, 6, 3, 23, 11 and 18) in 
Finland (Luotonen et al. 1981).  
Serotype changes due to recombinational exchanges at the capsular biosynthetic locus 
have been demonstrated among pneumococcal isolates (Coffey et al. 1998). However, 
Meats and coworkers did not find evidence of serotype changes when studying the naso-
pharyngeal pneumococcal isolates of children (Meats et al. 2003). Sequence analysis of 
the capsular biosynthetic genes of all 90 serotypes of S. pneumoniae (Bentley et al. 2006) 
will increase our knowledge of polysaccharide diversity, and may bring out new sero-
types and new tools for serotyping. 
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2.1.7 Pneumolysin and other virulence factors  
Pneumolysin (Ply) is an efficient intracellular toxin that can lyse any eukaryotic cell 
which has cholesterol in its membrane. Ply is a significant factor in pneumococcal viru-
lence. Ply consists of a single 53 kDa polypeptide chain and is a pore-forming toxin, ex-
pressed during the late log phase of growth and produced by virtually all clinical isolates. 
The toxin has several functions, particularly in the early phase of pneumococcal infection 
(Paton et al. 1993, Jedrzejas 2001). Its presence was earlier considered to be characteristic 
only to S. pneumoniae, but later on it has been shown that S. mitis and other α-hemolytic 
streptococci can also harbor the ply gene (Whatmore et al. 2000). 
Pneumococcal extracellular virulence factors can be divided into two groups: glycome-
based and proteome-based factors (Jedrzejas 2004). The first group uses sugars as build-
ing blocks and consists mainly of capsule polysaccharides and teichoic and lipoteichoic 
acids. The second group includes numerous surface-attached proteins and enzymes. This 
group can be divided further into three categories: peptidoglycan-bound proteins (e.g. 
hyaluronate lyase and neuraminidase), choline-binding proteins (pneumococcal surface 
protein A, choline-binding protein A, autolysin) and cytoplasmic lipid bilayer attached 
macromolecules (pneumococcal surface antigen A, formerly called pneumococcal surface 
adhesion A) (Paton et al. 1993, Jedrzejas 2004). 
Pneumococcal surface protein A (PspA) is the foremost studied surface protein among the 
numerous choline-binding proteins of S.pneumoniae (McDaniel et al. 1984, Novak & 
Tuomanen 1999). This highly variable protein (from 60 to 200 kDa) is produced by all 
pneumococci examined to date (Crain et al. 1990).  PspA has an important role in protect-
ing pneumococcus from the host immune system. It has been shown to be significant in 
the pathogenesis of disease. Its ability to bind lactoferrin may help it in the colonization 
of host mucosae. Recently it has been found that human lactoferrin has similar receptor-
like properties as PspA, but the significance of the finding is still under research 
(Jedrzejas 2004). 
Autolysins are a group of enzymes that degrade bacterial peptidoglycan. Their action 
leads to cell lysis. The major pneumococcal autolysin, S. pneumoniae N-acetylmuramoyl-
L-alanine amidase, also known as LytA amidase, belongs to extra-cellular choline-
binding proteins, and its size is 36 kDa. At the moment, the exact role of LytA in the viru-
lence of pneumococcus is unclear. Mutations of the lytA gene reduce virulence. More-
over, LytA induces protective antibodies in mice (Jedrzejas 2001). The lytA gene is the 
first bacterial autolytic gene that was cloned (Garcia et al. 1985). Obregon and coworkers 
(Obregon et al. 2002) presented that atypical pneumococcal isolates had mutations in the 
lyt A gene, and the gene has also been found in closely related streptococci (Llull et al.
2006). Bile solubility, which tests the ability of deoxycholate to dissolve the cell wall of 
streptococci, depends on the presence of the autolysin gene lytA (Obregon et al. 2002). 
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Pneumococcal surface antigen A (PsaA) protein (37 kDa) is also an important virulence 
factor. This extracellular, lipid-attached protein is part of a bacterial transport system and 
provides for the transport of Mn2+ and Zn2+ into the cell (Jedrzejas 2004). Morrison and 
coworkers (Morrison et al. 2000) have detected by using a PCR that all 90 serotypes of S.
pneumoniae contain the psaA gene. However, this gene has also been detected in other 
streptococcal species such as S. mitis, S. oralis and S. anginosus (Jado et al. 2001). 
Pneumococcal proteins are under abundant research as new vaccine candidates  (Jedrzejas 
2001, Bogaert et al. 2004). One recent publication demonstrates that intranasal immuniza-
tion with a cholera toxin B subunit-PsaA fusion protein is able to protect mice against 
pneumococcal colonization (Pimenta et al. 2006). 
Recent sequence analysis of the whole genome of the pneumococcal strains TIGR4 
(Tettelin et al. 2001), R6 (Hoskins et al. 2001), serotype 23F strain and serotype 6B strain 
670 (sequence information via the NCBI site at http://www.ncbi.nlm.nih.gov/sutils/genom-
_table.cgi) has made it possible to study  pneumococcal virulence factors in more detail. 
According to Jedrzejas (Jedrzejas 2004), sixty-six surface proteins have been identified, but 
only 56 % of them have been characterized or functionally worked out. New groups of viru-
lence factors, including Pht family proteins and signal peptidase, have been described 
(Jedrzejas 2004). Approximately 2200 genes of S. pneumoniae are known, and future re-
search will most likely bring out new virulence factors. The question remains why S. pneu-
moniae is a pathogen, but S. mitis and S. oralis are not (Hollingshead & Briles 2001). 
2.2 Identification methods 
In early times, the only way to detect and identify pneumococcus was to inoculate a small 
amount of sputum into the peritoneal cavity of white mice. After death, mouse blood was 
drawn and cultivated in broth and on blood agar plates and the colonies were examined 
(see White 1938). Later, a mouse virulence test was used as a “gold standard” in pneumo-
coccal studies (Bowers & Jeffries 1955, Converse & Dillon 1977, Wasilauskas & Hamp-
ton 1984). In the 1880s, Gram made his staining experiments to visualize the bacteria 
from lung tissue specimens and found bacteria that were stained dark with aniline genti-
ane violet while others were not (White 1938). Pneumococcus was one of the first bacte-
ria demonstrated with the Gram stain (Watson et al. 1993).   
Pneumococcus is routinely identified by four phenotypic characteristics: colony morphol-
ogy on a blood agar plate, bile solubility, optochin sensitivity and the presence of a cap-
sule (Lund 1959, Austrian 1975, MacFaddin 1976, Lund & Henrichsen 1978, Mundy et 
al. 1998, Ruoff et al. 2003). Already very early, researchers found discrepancies between 
these characteristics, but still, identification based on them remained practical and cost-
effective. A thorough comparison of the available biochemical and serological methods 
was published recently, pointing to the high sensitivity but limited specificity of most of 
the phenotypic tests (Kellogg et al. 2001). Later on, developed diagnostic molecular 
methods have made it possible to identify bacterial isolates through the presence of toxins 
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(Rudolph et al. 1993), antimicrobial resistance genes (Ubukata et al. 1996) and exact 
components of genes, e.g. lyt A (Pozzi et al. 1989, Fenoll et al. 1990, Hassan-King et al.
1994, Obregon et al. 2002). However, today most clinical laboratories still use the opto-
chin sensitivity test or the bile solubility test as a screening test to differentiate pneumo-
coccus from other α-hemolytic streptococcal isolates (Mundy et al. 1998, Ruoff et al.
2003). The molecular methods have provided important tools for epidemiological surveil-
lance (Lefevre et al. 1993, Enright & Spratt 1999), too.  
2.2.1 Optochin sensitivity test
In 1911 Morgenroth and Levy found that quinine 
and some of its derivates have a bactericidal prop-
erty for pneumococcus both in vitro and in vivo.
Unfortunately, quinine proved to be toxic in doses 
that could be useful in the treatment of pneumo-
coccal pneumonia. In 1915 Moore noticed that 
among streptococci, S. pneumoniae was most sen-
sitive to a quinine derivate, ethylhydrocupreine 
(see White 1938). In 1943 Mørch demonstrated 
that ethylhydrocupreine hydrochloride (optochin) 
in low concentrations on blood agar would inhibit 
pneumococcal growth (Mørch 1943) (Fig. 3). Ten 
years later, the phenomenon was found to be suitable for differentiation of pneumococcus 
from other α-hemolytic streptococci. A paper disc with diluted optochin was placed on a 
cultured blood agar plate, and after incubation the inhibition zone was measured (Bowers 
& Jeffries 1955). The usefulness of the test was strengthened by Bowen and coworkers, 
who showed that inhibition was present with all the different serotypes (Bowen et al.
1957). Lund (Lund 1959) confirmed these findings and showed optochin sensitivity to be 
a more reliable method than bile solubility in the differentiation of pneumococcus and 
other streptococci. When smooth, capsulated, virulent pneumococci are changed into 
rough, unencapsulated, avirulent pneumococci, they keep their optochin sensitivity but 
lose their bile solubility (Lund 1959). 
Optochin sensitivity is commonly used and often the only identification test for pneumo-
coccus (Austrian 1975, MacFaddin 1976, Mundy et al. 1998). Incubation in the presence 
of carbon dioxide has been shown to influence the size of the inhibition zone (Ragsdale & 
Sanford 1971). Blood is essential for inhibition as the first finding showed (Mørch 1943), 
but the agar medium used may also have an influence on the size of the inhibition zone. A 
trypticase soy medium with sheep blood and incubation in a carbon dioxide atmosphere 
proved to be the most suitable conditions for testing optochin sensitivity (Gardam & 
Miller 1998). 
Fig. 3. Optochin sensitivity test.
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Very early observations showed that pneumococcal cells could lose their sensitivity to 
optochin (see White 1938, Bowers & Jeffries 1955), and 30 years later optochin-resistant 
pneumococcal isolates were described. One of the earliest reports came from Finland 
(Kontiainen & Sivonen 1987). Later, in 1995-99 in Finland, the percentage of partly op-
tochin-resistant invasive isolates was 2.5 % (59/2357), and fully resistant, 0.2 % (unpub-
lished observation in the National Reference Laboratory for Pneumococcus, National 
Public Health Institute, Oulu). Most of the isolates grew as mixed cultures containing 
both optochin-sensitive and resistant colonies. Pikis and coworkers (Pikis et al. 2001) 
reported optochin resistance in only 0.5 % of the strains isolated from sterile specimens 
(blood, CSF) of children in Washington, USA, during 1992-1998. The optochin resis-
tance of S. pneumoniae is a result of point mutations in either the ATP-ase a- or c-subunit 
(Cogne et al. 2000, Pikis et al. 2001). The origin of optochin-resistant variants is still 
unclear. An interesting discovery was the connection between optochin resistance and the 
modern increased treatment and prophylaxis of malaria; optochin is similar to quinine and 
mefloquine (Pikis et al. 2001). 
2.2.2 Bile solubility 
Neufeld first noticed in 1900 that bile has the property of being able to dissolve the 
pneumococcal cell. This property later became an important diagnostic property for dif-
ferentiating pneumococcus from other streptococci. Neufeld also found that only freshly 
isolated and virulent pneumococcal strains were bile soluble. Levy (1907) used sodium 
taurocolate in 5 % and 10 % dilutions to dissolve pneumococcus and believed that the 
method could differentiate all pneumococci from other bacterial species (see White 1938, 
Lund 1959). Later studies demonstrated that bile solubility and optochin sensitivity have 
almost complete correlation, and strains with unclear results in a bile test were avirulent 
in a mouse virulence test (Bowers & Jeffries 1955). More evidence of the usefulness of 
the bile test came from observations that other streptococci were not soluble in bile (Lund 
1959, Wasilauskas & Hampton 1984), but in 10 % of cases the interpretation was uncer-
tain (Lund 1959). 
2.2.3 Identification tests based on biochemical characteristics 
Bacteria have several physiological and biochemical characteristics by which they can be 
differentiated from other species. Enzymatic activity or the fermentation of sugars by 
streptococci can be demonstrated in the laboratory using the procedures described earlier 
(Kilian et al. 1989, Facklam & Washington 1991). Commercial, standardized identifica-
tion tests have been developed to make biochemical identification easier. In the 1970s, 
the authorities Colman and Williams in the UK (Colman & Williams 1972) and Facklam 
in the USA (Facklam 1977) had a disagreement concerning the grouping and nomencla-
ture of viridans streptococci. The different conceptions of nomenclature have complicated 
the interpretation of identification results (French et al. 1989, Beighton et al. 1991) . 
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There are several studies on the physiological and biochemical differentiation of viridans 
streptococci in the literature,  (Facklam 1977, Colman & Ball 1984, French et al. 1989, 
Coykendall 1989, Kilian et al. 1989, Beighton et al. 1991, Facklam 2002). S. pneumoniae
is included in the viridans group. Pneumococcal isolates can easily be differentiated from 
the rest of the viridans group by means of their optochin sensitivity and bile solubility 
(Colman & Williams 1972, Facklam 1977). On the other hand, the difficulty in identify-
ing S. pneumoniae using biochemical tests is known (Colman & Ball 1984). According to 
Norris (Norris 1968), if two bacterial strains carry out the same enzymic activities, it is 
difficult to say whether they produce exactly the same enzyme molecules or whether they 
produce similar enzymic activities produced by different molecules. In the latter situation 
there is no direct relationship at the genetic level.
Tillotson (Tillotson 1982) compared the improved API 20 STREP identification kit 
(bioMerieux, Marcy l′Etoile, France) with conventional physiological identification tests. 
The kit had occasional problems in differentiating some streptococcal groups, but identi-
fied viridans streptococci excellently. S. pneumoniae is included in the viridans group, but 
unfortunately no pneumococcal strain was included. However, the identification should 
be confirmed by colony morphology, optochin sensitivity and bile solubility according to 
the recommendation of the manufacturer (Tillotson 1982). Colman and Ball (Colman & 
Ball 1984) also recommended that the API system should be used together with other 
tests, e.g. Lancefield grouping and sensitivity tests. According to French (French et al.
1989), the API 20 STREP system may be more reliable than conventional biochemical 
test methods, although the identification codes need revision. The RapID STR system 
(Innovative Diagnostic Systems, Inc., Atlanta, Ga.) correctly identified 88.5 % of 
S.pneumoniae and 72.5 % of the viridans strains when an optochin sensitivity test was 
used simultaneously, as the manufacturer recommended for all α-hemolytic strains. 
Without optochin testing the correct identification of S. pneumoniae was 26.9 % and the 
viridans group 52.3 %, respectively. The RapID STR system requires only four hours of 
incubation, but the need for additional tests decreases the rapidity of identification 
(Appelbaum et al. 1986).  
A review by Coykendall (Coykendall 1989) and a study by Kikuchi (Kikuchi et al. 1995) 
show how complicated and difficult the physiological and biochemical identification of 
viridans streptococci is, in spite of improved taxonomy based on molecular and genetic 
relationships. Pneumococcus has unfortunately been excluded from both studies, and thus 
biochemical and genetic descriptions of the bacterium are not available.  
2.2.4 DNA hybridization (AccuProbe¥)
In 1989 Pozzi and coworkers (Pozzi et al. 1989) described a DNA probe based on the 
lytA gene. In 1990 Fennoll and coworkers (Fenoll et al. 1990) reported an improved non-
commercial pneumococcal DNA probe based on a 0.65 Kb fragment coding of the amino-
terminal region of the major autolysin (lytA gene). They found the probe useful in identi-
31
fying atypical pneumococcal isolates and suitable for diagnostic use (Fenoll et al. 1990). 
Shortly after that a commercial probe kit became available.  
AccuProbe ¥ for S. pneumoniae is a commercial nucleic acid hybridization test that uses 
a single-stranded, chemiluminescent-labelled DNA complementary for ribosomal 16S 
RNA of S. pneumoniae. In 1992 Denys and Carey (Denys & Carey 1992) showed that the 
sensitivity and specificity of AccuProbe was 100 % compared with phenotypically identi-
fied pneumococcal and nonpneumococcal isolates. Geslin and coworkers (Geslin et al. 
1997) correctly identified 100 % of typical optochin-sensitive and capsulated pneu-
mocccal strains, but only 78 % of the optochin-sensitive, unencapsulated clinical strains 
were confirmed as pneumococci. In 1998 Mundy and coworkers (Mundy et al. 1998) 
reported that AccuProbe ¥ for S. pneumoniae had 100 % sensitivity and 100 % specific-
ity among phenotypically identified unequivocal pneumococcal and nonpneumococcal 
isolates. However, among 115 equivocal isolates that did not express all the typical 
pneumococcal characteristics, four (3 %) optochin-sensitive isolates were not identified 
as S. pneumoniae (Mundy et al. 1998). Kearns (Kearns et al. 2000) agreed with Mundy 
on the suitability of AccuProbe ¥ in pneumococcal identification, although they identi-
fied as S. pneumoniae five phenotypically nonpneumococcal isolates.  Later studies 
showed that the accuracy of AccuProbe ¥ for S. pneumoniae is lower than it was earlier 
reported (Messmer et al. 2004), and according to Whatmore and coworkers (Whatmore et 
al. 2000), AccuProbe ¥ identified many atypical pneumococcal isolates as pneumococci, 
although they probably represented organisms that are genetically rather divergent from 
typical pneumococci. 
In 1991 Davis and Fuller described a flow chart for several bacterial species used in the 
direct identification of positive blood cultures with AccuProbe¥. All 24 positive pneu-
mococcal blood cultures were correctly identified as S. pneumoniae with AccuProbe¥
(Davis & Fuller 1991). Later results confirmed the usefulness of the method, but the ad-
justed values for the reflective light units (RLU) of AccuProbe¥ kits, calculated by the 
authors, improved the usability of direct identification (Lindholm & Sarkkinen 2004). For 
example, for pneumococcus the sensitivity was 97.9 % and the specificity was 100 % 
compared with conventional identification methods using a continuously monitoring 
blood culture system and Gram staining (Lindholm & Sarkkinen 2004). 
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2.2.5 Demonstration of the capsule 
Pneumococcal capsular polysaccharides can be detected 
with several serological methods using specific pneumo-
coccal antisera. The quellung reaction, first described by 
Neufeld in 1902 (see White 1938), continues to be the 
basic method used in the detection of a pneumococcal 
capsule (Fig. 4). This method has also been used for other 
bacterial species (Austrian 1976). The quellung reaction 
with polyvalent and specific antisera is the most specific 
identifying and serotyping method, but it requires much 
experience and a large panel of antisera. Therefore, it is 
not routinely used in clinical bacteriological laboratories, 
but mainly in reference and research laboratories. How-
ever, the method is used as a gold standard in compari-
sons with other methods. Other serological methods, such as latex agglutination (Severin 
1972, Leinonen 1980), counterimmunoelectroforesis (CIEP) (Coonrod & Rytel 1972), 
coagglutination (Kronvall 1973) and dot blot assays (Fenoll et al. 1997), have been de-
veloped for serotyping.  
A pneumococcal omniserum (Statens Serum Institut, Copenhagen, Denmark) contains 
antibodies against all 90 serogroups/types, and thus by using one reagent, the presence of 
a capsule can be detected in an isolate or a specimen. However, several streptococcus 
species with a carbohydrate capsule as well as other encapsulated bacteria, such as H. 
influenzae (Zepp & Hodes 1943), the klebsiella species (Heidelberger & Nimmich 1972) 
and E. coli (Robbins et al. 1972), and Bacillus with a polypeptide capsule (Tomcsik 
1956), can cross-react with the pneumococcal antiserum. Reactions with other proteins 
that are not antibodies, such as C-reactive protein, may also cause a positive quellung 
reaction (Löfström 1944, Bornstein et al. 1968, Austrian 1976). Omniserum and antise-
rum pools contain low concentrations of antibodies against the pneumococcal cell wall 
(Henrichsen et al. 1980), and this has to be taken into account in interpreting the results. 
In one study as many as 68 % of α-hemolytic clinical streptococci showed cross-
reactivity with the pneumococcal omniserum (Holmberg et al. 1985). 
Modifications of the described methods have been used to detect pneumococcus from 
patient specimens (Merrill et al. 1973, Austrian 1976, Singhal et al. 1996), to detect a 
pneumococcal capsule in isolates, and thus as a part of the identification (Cima-Cabal et 
al. 1999, Chandler et al. 2000, Kellogg et al. 2001) in serotyping (Henrichsen et al. 1980, 
Lalitha et al. 1996, Lalitha et al. 1999, Arai et al. 2001, Slotved et al. 2004) and in a 
comparison with other methods (Wasilauskas & Hampton 1984, Fenoll et al. 1997, Mun-
dy et al. 1998, Kearns et al. 2000). A molecular approach to serotyping is the PCR 
method based on polymorphisms within the cpsA and cpsB genes that are common to all 
Fig. 4. Quellung reaction, de-
tection of the capsule of sero-
type 7F.
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capsule loci (Lawrence et al. 2000). It has been modified for use as a multiplex PCR 
method and as a semiautomated method (Lawrence et al. 2003). 
2.2.6 Demonstrations of virulence genes using a polymerase chain reaction (PCR)  
The polymerase chain reaction (PCR) method was first 
described by Mullis in 1987 (Mullis & Faloona 1987). 
The method is based on the amplification of a fragment of 
the gene, where the amplified products can be detected by 
agarose gel electrophoresis (Norris 1968, Erlich et al.
1991, Bingen et al. 1994) or by using a microwell hy-
bridization reaction, e.g. with an Europium-labelled probe 
(Dahlen et al. 1988). A real-time PCR, with amplification 
and detection of the target product in real time and simul-
taneously using fluorescent measurements and specific 
dyes, brought several advantages for gene technology. 
Confirmation of products and differentiation of a specific 
product from nonspecific products using melting tem-
perature increases the sensitivity and specificity of the PCR (Wittwer et al. 1997b, Witt-
wer et al. 1997a). The amplification curves (top in the figure) and melting peaks of the 
amplification products (bottom in the figure) of a streptococcal strain, a pneumococcal 
standard and a negative control are presented in Figure 5.  
Conventional and real-time PCR methods have been used to detect pneumococcal viru-
lence factors from clinical specimens and from pneumococcal isolates. Pneumolysin is 
the most often used virulence factor in pneumococcal identification (Rudolph et al. 1993, 
Kearns et al. 2000, Neeleman et al. 2004b). A ply PCR has been used to demonstrate 
pneumococcus directly from blood (Rudolph et al. 1993, Toikka et al. 1999), from ce-
rebrospinal fluid (Kearns et al. 1999), from serum (Salo et al. 1995, Salo et al. 1999) 
from middle ear fluid (Virolainen et al. 1994, Jero et al. 1996, Saukkoriipi et al. 2002) 
and from a nasopharyngeal specimen (Saukkoriipi et al. 2004).  
PCR methods based on the demonstration of various other pneumococcal virulence fac-
tors, such as autolysin (lytA) (Rudolph et al. 1993, Ubukata et al. 1996, Whatmore et al.
2000, McAvin et al. 2001, Messmer et al. 2004, Neeleman et al. 2004a), pneumococcal 
suface antigen A (psaA) (Messmer et al. 2004), manganese-dependent superoxide dismu-
tase (sodA) (Kawamura et al. 1999) and penicillin-binding protein (Zhang et al. 1995, 
Ubukata et al. 1996), have also been developed. Messmer and coworkers (Messmer et al.
2004) found that an lytA PCR was the most specific in differentiating pneumococcus from 
atypical streptococci compared with conventional, AccuProbe™-, ply, and psaA PCR
methods. The number of new molecular methods for identifying pneumococcus and dif-
ferenting pneumococcus from other streptococcal species is still increasing (Suzuki et al.
2005, Innings et al. 2005).  
Fig. 5. Real-time ply PCR with 
melting curve analysis.
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2.2.7 Genotyping methods 
The characterization of bacterial pathogens below the species level is essential in analyz-
ing the clonal spread of bacteria during epidemics and in identifying antibiotic-resistant or 
otherwise virulent isolates. Molecular typing methods are useful in studying a short-term 
(the spread of an isolate of a hospital or local community) as well as a longer-term (global 
spread of virulent isolates) epidemiological follow-up (Bingen et al. 1994, Hall 1998, 
Enright & Spratt 1999). For pneumococcal epidemiology, accurate typing methods, such 
as pulsed-field gel electrophores (PFGE) (Lefevre et al. 1993, Bingen et al. 1994, Hall et 
al. 1996), multilocus enzyme electrophoresis (MLEE) (Selander et al. 1986, Takala et al.
1996, Hall et al. 1996), restriction fragment length polymorfism (RFLP) (Bingen et al.
1994, Lawrence et al. 2000, Doit et al. 2002, Schlegel et al. 2003) and multilocus se-
quence typing (MLST) (Enright & Spratt 1998, Spratt 1999), have been developed. The 
amplified fragment length polymorphism (AFLP) method is one application of the RFLP 
–method, and it has also been used in pneumococcal serotyping (Neeleman et al. 2004a, 
Shaaly et al. 2005, Batt et al. 2005). In addition, amplified rDNA restriction analysis 
(ARDRA) has been used especially to identify bacteria growing slowly in a culture, such 
as a mycobacterial species (De Baere et al. 2002). 
The PFGE method is based on the evaluation of total chromosomal DNA, and the ob-
tained PFGE type is compared with similarity and diversity patterns. It is commonly used 
and considered as a gold standard (Lefevre et al. 1993, Shaaly et al. 2005). Neeleman and 
coworkers (Neeleman et al. 2004a) compared the AFLP method with the PFGE method 
and found that it differentiates pneumococci from other streptococci better than the “gold 
standard” PFGE method. Several modifications of the RFLP analysis have been used in 
the epidemiological follow-up of pneumococcus (Doit et al. 2002, Schlegel et al. 2003) 
and in the evaluation of DNA-based methods (Lawrence et al. 2000).  
The multilocus sequence typing (MLST) system provides a new approach to the charac-
terization of pneumococci, and it is described at http://www.mlst.net/: “Multilocus se-
quence typing (MLST) is an unambiguous procedure for characterizing isolates of bacte-
rial species using the sequences of internal fragments of seven housekeeping genes.  
Approx. 450-500 bp internal fragments of each gene are used, as these can be accurately 
sequenced on both strands using an automated DNA sequencer. For each housekeeping 
gene, the different sequences present within a bacterial species are assigned as distinct 
alleles and, for each isolate, the alleles at each of the seven loci define the allelic profile 
or sequence type (ST)”. In other words, in MLST, the internal fragments of the seven 
housekeeping genes aroE, ddl, gdh, gki, recP, spi and xpt are amplified, sequenced and 
after comparison with known alleles, their allelic profile is specified. This profile (ST) is 
compared with allelic profiles and defined in a database via the Internet (Enright & Spratt 
1998, Enright & Spratt 1999). 
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2.3 Demonstration of pneumococcal carriage 
2.3.1 Pneumococcus as a part of normal nasopharyngeal flora 
Bacterial colonization starts immediately after birth and 
continues throughout life with small changes. Normal na-
sopharyngeal bacterial flora develops during the first year 
of life and the number of bacterial species varies much 
(Aniasson et al. 1992, Harrison et al. 1999). Normal flora 
has an important role in the prevention of infectious dis-
eases. However, a major part of infections is caused by 
microbes like S. pneumoniae, H. influenzae, M. catar-
rhalis, N. meningitidis and Staphylococcus aureus, which 
originally belong to normal flora (Fig. 6). Pneumococcus 
has genetic properties allowing it to coexist with other 
bacteria and inhibit competing intruders, and by producing 
hydrogen peroxide it inhibits the growth of other bacteria such as H. influenzae, M. catar-
rhalis and N. meningitidis (Pericone et al. 2000). Alpha-hemolytic streptococci isolated 
from the nasopharynx of healthy children have been shown to inhibit the growth of S.
pneumoniae, H. influenzae and M. catarrhalis (Tano et al. 1999, Bogaert et al. 2004). 
Aniansson and coworkers studied (Aniasson et al. 1992) the development of nasopharyn-
geal bacterial colonization. The bacteria that were common in the nasopharynx of Swed-
ish children at 2 months of age were diphteroid rods (39 %), S. aureus (39 %) and M.
catarrhalis (20 %), S. epidermidis (15 %), α-hemolytic streptococci (13 %), S. pneumo-
niae (12 %) and H. influenzae (5 %). Their percentages changed to 35 %, 4 %, 40 %, 9 %, 
20 %, 32 % and 13 %, respectively, at 10 months of age. The proportion of children car-
rying S. pneumoniae, H. influenzae or M. catarrhalis increased with age from 31 % at 2 
months to 62 % at 10 months of age (Aniasson et al. 1992). Harrison and coworkers 
(Harrison et al. 1999) confirmed these findings when they studied nasopharyngeal bacte-
rial flora in infancy and sleep position. 
Pneumococcal carriage develops among children more rapidly in developing countries 
compared with industrialized countries, and more than one serotype can be carried simul-
taneously for several months (O'Brien & Nohynek 2003).  For example, in Papua New 
Guinea, pneumococcal carriage was 36 % among children under 10 days old and in-
creased to 100 % at 80 days of age (Gratten et al. 1986). On the other hand, in Costa 
Rica, pneumococcal carriage was low and increased from 3.1 % at one month of age to 
19.4 % by the end of the first year (Vives et al. 1997). In Finland, pneumococcal carriage 
in healthy children increased from 9 % at 2 months of age to 22 % at 12 months and to 43 
% at 24 months (Syrjänen et al. 2001). Respiratory infection with acute otitis media in-
creased carriage up to 56 %, and with pneumococcal AOM it was 97-100 % (Syrjänen et 
al. 2001). Young children (< 6 months) are well protected from pneumococcal carriage, 
Fig. 6. Culture from naso-
pharyngeal specimen and iden-
tified pneumococcus.
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but carriage in families raised the risk tenfold compared with children whose family 
members did not carry the bacteria (Leino et al. 2001).  
People usually carry pneumococci without symptoms, but carriage can also contribute to 
respiratory or even systemic disease. Nasopharyngeal pneumococcal carriage has been 
studied much over the years, as recently published reviews show (Garcia-Rodriguez & 
Fresnadillo Martinez 2002, O'Brien & Santosham 2004, Bogaert et al. 2004). Several 
factors, such as age, geographical sites, socio-economic status, family size, number of 
siblings, day-care, the presence of upper respiratory tract infection and overcrowded liv-
ing conditions, have considerable impact on pneumococcal carriage and its rates (Garcia-
Rodriguez & Fresnadillo Martinez 2002, O'Brien & Santosham 2004, Bogaert et al.
2004). In addition, a comparison of pneumococcal carriage rates between studies is diffi-
cult due to the variable methodological factors, such as the number and frequency of 
specimen collection, the quality of specimens and culture techniques (Garcia-Rodriguez 
& Fresnadillo Martinez 2002). Generally, pneumococcal carriage is highest at the age of 
two years and it decreases over the years. Most of the carriage studies have been done 
among children, but some cover age groups up to adults (Christenson et al. 1997, Borer et 
al. 2001). Table 2. shows the pneumococcal carriage, the specimen, and the method used 
among different age groups.
Table 2. Pneumococcal carriage among children, adolescents and adults.
Coun-
try
Year Studied popula-
tion 
Specimen Serotyping Age Car-
riage
rate
Sweden 
(Chris-
tenson
et al.
1997) 
1995 1129 day-care 
children, aged 2-7 
years, and 308 
adults 
Nasopharyngeal 
swab in a trans-
port medium, 
cultured within 
24 hours. 
CIEP (an-
tisera from 
SSI)
2 years      
4 years      
7 years 
adult 
50 %  
42 %  
21 %    
3 % 
Israel
(Borer
et al.
2001) 
1998 152 children and 
adolescents and 
244 adults 
Nasopharyngeal 
swab in a modi-
fied Stewart 
transport me-
dium, cultured 
within 1 hour. 
Quellung 
reaction
(antisera 
from SSI) 
< 2 years 
2-5 years 
6-12 years 
13-17 yrs 
adults 
75 %  
53 %  
40 %  
10 %    
7 % 
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2.3.2 Transport of a specimen  
The ideal situation, that a specimen would be cultured on plates immediately after sample 
collection, is usually impossible, as sample collection and isolation and identification of 
bacteria are carried out in separate places. The main requirement of a useful transport 
pack is to store the bacteria viably, uncontaminated and without variation or mutation, i.e. 
to keep the bacteria as nearly as possible in a state that corresponds to the original isolate. 
In early times of bacteriology (in the 1890s), cotton wool swabs were used to transport 
the clinical specimens, but transportation in a dry swab should happen without delay. A 
significant improvement in specimen transport was offered by the medium that Stuart, 
Toshach and Patsula described in 1954 (Stuart 1956). Agar jelly containing sodium 
thioglycollate to prevent oxidation, but no nutrient material, was found to be suitable for 
keeping such bacteria as Neisseria and Shigella viable during transport (Stuart 1956). 
This medium, with modifications, became the commonly used specimen transport 
method. Comparisons of commercial transport packs have shown that their ability to keep 
bacteria viable varies, and overgrowth of other nonpathogenic bacteria may cause prob-
lems (Human & Jones 1986). The dry swab without any medium gave similar results as 
many commercial packs if the specimen was plated within six hours. However, a delay of 
24-48 hours illustrated the value of the transport medium (Human & Jones 1986). 
In pneumococcal carriage studies, the number of collected specimens is high. In addition, 
the cost and limitations of commercial packs created a need to find a suitable medium for 
research purposes. In 2001 O´Brien and coworkers (O'Brien et al. 2001) showed that an 
STGG (skim milk-tryptone-glucose-glycerol) medium is excellently suited for nasopharyn-
geal carriage studies. Their results showed that low amounts of pneumococcus are recov-
ered better from a nasopharyngeal swab in an STGG medium than from direct plating. 
Storage for nine weeks at temperatures of –70°C and –20°C did not decrease the recovery 
of pneumococcus, whereas storage for five days at + 4oC reduced pneumococcal growth 
(O'Brien et al. 2001). Later, it has been confirmed that samples in an STGG or SGG (skim 
milk-glucose-glycerol) medium could be stored at refrigerator temperature for up to three 
days without a significant loss of pneumococcal viability (Charalambous et al. 2003).  
However, storage of specimens in commercial transport packs and also in STGG tubes has 
disadvantages, such as a need for rapid processing (24 hours), the high cost of a low-
temperature freezer and an expensive component of the medium. Thus, other storage media 
for nasopharyngeal specimens have been studied. The SGG medium is more economical 
compared to the STGG medium and stored pneumococci survive well, but the STGG me-
dium preserved pneumococci significantly better at + 21°C and + 30°C than did SGG 
(Charalambous et al. 2003). A modified Dorset egg (DE) medium stores pneumococcal 
colonies viably for at least 30 days without refrigeration, but further studies are needed to 
evaluate its suitability for nasopharyngeal swabs and other respiratory pathogens (Wasas et 
al. 1998). An egg-thioglycolate-antibiotic (ETA) medium was also used in nasopharyngeal 
swabs to store pneumococcus viably. The results showed that 94 % of the pneumococci 
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stayed viable at + 20°C for 7 days and 85 % for 14 days, and failure to recover pneumococ-
cus was usually due to an overgrowth of α-hemolytic streptococci (Gray 2002). 
In 2003 the WHO’s Working Group published (O'Brien & Nohynek 2003) a standardiza-
tion of the methods for detecting S. pneumoniae in nasopharyngeal carriage studies.
2.3.3 Bacterial preservation 
An ultra-freeze method with a modified medium was used to study the survival of bacte-
ria among 97 fastidious bacterial species (Gibson & Khoury 1986). The medium was 
composed of tryptone soya broth, glucose, skim milk and glycerol. Skim milk combined 
with the glycerol proved to be an excellent cryoprotectant, and transporting the tubes 
immediately into a freezer at –70°C increased bacterial viability. S. pneumoniae stayed 
viable for 40 months and H. influenzae for 28 months (Gibson & Khoury 1986). An 
STTG medium has been used successfully to store both bacterial isolates and naso-
pharyngeal specimens viably (O'Brien et al. 2001), and bacterial viability remains un-
changed for several years (in Gray 2002 personal observations). 
2.3.4 Detection of pneumococcus from an STGG medium  
Pneumococcus can be detected from nasopharyngeal specimens by using direct plating 
(Syrjänen et al. 2001), but the method needs competent circumstances for isolating and 
identifying bacteria or special transportation to a bacterial laboratory. Direct plating is as 
sensitive as a culture from an STGG medium, but, however, in low bacterial concentra-
tions pneumococcus could be detected better with a culture from an STGG medium 
(O'Brien et al. 2001). Charalambous and coworkers (Charalambous et al. 2003) showed 
that direct plating was not as sensitive as culturing from an STGG medium. 
An STGG medium has several advantages compared with direct plating. Specimens col-
lected in an STGG medium can be used not only for bacterial cultures, but also for other 
detection methods. Pneumococcus can be detected from nasopharyngeal specimens in an 
STGG medium also by using a real-time ply PCR (Saukkoriipi et al. 2004) that enables 
the detection of nonviable pneumococci, e.g. during antibiotic treatment. A recently pub-
lished study shows that the medium can be used to simultaneously detect viral and bacte-
rial pathogens (Pitkäranta et al. 2006), and several bacteriological studies (Ukkonen et al.
2000, Kristo et al. 2006, Herva et al. 2006) have shown its usefulness.
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3 AIMS OF THE STUDY 
The purpose of the study was to compare the conventional, phenotypic bacteriological 
and genetechnological methods of identifying Streptococcus pneumoniae and especially 
to evaluate their usefulness in the identification of suspected pneumococcal isolates lack-
ing one or more of the typical characteristics of pneumococcus. The specific aims were: 
1. To compare the phenotypic identification methods and a biochemical method (API 20 
STREP), a hybridization method (AccuProbe¥) and genetechnological methods with 
each other in the identification of S.  pneumoniae (I, II, III). 
2. To evaluate a real-time ply PCR combined with melting curve analysis of amplification 
products in the differentiation of S. pneumoniae from other α-hemolytic streptococci (III). 
3. To evaluate the usefulness of an STGG medium for the transportation and storage of 
nasopharyngeal specimens and bacterial isolates at –20oC and –80oC (IV). 
40
4 MATERIALS AND METHODS 
4.1  Bacterial isolates 
The study material in paper I consisted of 100 α-hemolytic streptococcal isolates sus-
pected to be pneumococci. The isolates were divided into four groups according to their 
optochin sensitivity and capsular reaction. Figure 7. shows the pneumococcal isolates, 
their origin and classification. S. pneumoniae ATCC 6305 (ATCC CULTURES¥) was 
used as a positive and S. bovis ATCC 9809 (ATCC CULTURES¥) as a negative control 
strain.
100 pneumococcal strains 
49 optochin sensitive strains 51 optochin resistant strains 
24 capsule + 25 capsule - 15 capsule +
- 25 from eye or other 
superf. mucous 
membrane samples
- 10 from eye or other 
superf.mucous 
membrane 
- 5 from blood or CSF 
36 capsule - 
- 35 from eye or other 
mucous membrane 
- 1 from blood 
- 15 from blood or CSF 
- 9 eye or other superficial 
mucous membrane 
samples 
Fig. 7. Isolates used in study I.
The reference strains of S. pneumoniae, S. mitis, S. oralis and S. sanguinis and 49 opto-
chin-resistant α-hemolytic streptococcal pneumococcus-like isolates are presented in 
original paper II. The optochin-resistant clinical isolates are the same isolates that were 
used in paper I and had been sent to the Reference Laboratory (KTL, Oulu, Finland) for 
confirmation of identification and serotyping. 
In paper III, the study material originally consisted of 100 α-hemolytic streptococcal 
strains isolated from consecutive nasopharyngeal swabs of young children. The children 
(N:507) participated in a study where the efficacy of 3´- sialyllacto-N-neotetraose in the 
prevention of otitis media was studied (Ukkonen et al. 2000). Isolated, α-hemolytic colo-
nies, either optochin-sensitive or -resistant, were stored in 10 % skim milk (Difco 0032-
17-3, USA) at −80 °C for further testing. Unfortunately, three optochin-resistant isolates 
were not viable after storage, and our final material thus consisted of 97 isolates. S.
pneumoniae ATCC 6305 was used as a positive and S. bovis ATCC 9809 as a negative 
quality control strain. 
In paper IV, S. pneumoniae (ATCC 6305), M. catarrhalis (ATCC 25238) and H. influen-
zae (a clinical isolate) strains were used to test the survival of these bacteria in an STGG 
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medium at –20oC and at –80oC.  In addition, the survival of S. pneumoniae, H. influenzae
and M. catarrhalis in nasopharyngeal specimens stored frozen at –80oC for one and a half 
year before subculturing was studied. Nasopharyngeal samples were collected in an 
STGG medium from children participating in an NE-1530 study (Ukkonen et al. 2000). 
4.2 Ethical issues 
The selected study material, pneumococci or streptococci suspected of being pneumo-
cocci (papers I and II), belong to the isolate collection of the National Infectious Diseases 
Register of the National Public Health Institute, Finland. The strains have been isolated 
from blood or cerebrospinal fluid or other sterile fluids or from other specimens with 
decreased penicillin sensitivity. Originally, the strains had been identified as pneumococ-
cus in clinical microbiological laboratories and had been sent for confirmation of identifi-
cation and for serotyping to the National Reference Laboratory for Pneumococcus. The 
Communicable Diseases Act (583/1986) with several regulations permit the use of iso-
lates for research purposes. 
The nasopharyngeal specimens and isolates used in papers III and IV were collected from 
children that were recruited from the Helsinki metropolitan area. Their age was 10-24 
months and they were in good health, as confirmed by their medical history and complete 
physical examinations. In the study, the efficacy of antiadhesive oligosaccharide 3´-
sialyllacto-N-neotetraose (NE-1530) was investigated as a prevention or treatment of 
infections of acute otitis media and for its effect on the nasopharyngeal carriage of bacte-
ria (Ukkonen et al. 2000). The study protocol was approved by the National Agency for 
Medicines and the ethics committees of the Helsinki City Health Department and the 
National Public Health Institute, Helsinki. 
The work was carried out according to good research practise at KTL. Good research 
practice, version 1.0 (Lankinen & Laitinen 1998) contains recommendations, guidelines 
and legislation concerning research at KTL and describes the practices to be followed. 
4.3  Conventional identification methods 
4.3.1 Optochin sensitivity test (I, II, III, IV)
Based on our findings in paper I, all optochin sensitivity tests in studies II and III were 
performed using heavy inoculum and optochin discs purchased from Biodisk. Thus, 5-10 
colonies were touched with a disposable 1 μl loop and streaked on a blood agar plate and 
a Biodisk optochin disc was placed in the middle of the inoculated area. The plate was 
incubated in 5 % CO2 at + 37 °C for 18-24 hours and the inhibition zone was measured 
(mm). Optochin sensitivity was interpreted as optochin-sensitive (≥ 12 mm) or optochin-
resistant, using the manufacturer′s cutoff value. 
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4.3.2 Tube bile solubility test (I, II, III) 
Bile solubility was tested according to the method described by Facklam and Washington 
(Facklam & Washington 1991). Fresh pneumococcal growth from a blood agar plate was 
suspended in 0.9 % NaCl to give 0.5-1.0 McFarland units. Equal 0.5 ml volumes were 
transferred into two tubes, and 0.5 ml of 2 % sodium deoxycholate (Merck 6504, Ger-
many) or 0.5 ml of 0.9 % NaCl (control) was added. The tubes were incubated for 2 hours 
in 5 % CO2 at + 37 °C. Disappearance of opacity in the deoxycholate tube, but not in the 
control tube, was interpreted as a positive result. Partial clearing was not accepted as a 
positive result. 
4.3.3 Demonstration of the presence of a capsule by quellung reaction (I, II, III)
A capsular quellung test was performed as described by Austrian (Austrian 1976) to 
demonstrate the presence of a capsule in pneumococcal isolates. Fresh growth was trans-
ferred from a blood agar plate into 4 ml of brain heart infusion broth (Difco 0037-17-8, 
USA) with 10 % horse serum (Life Technologies¥ 26050-047, England) and incubated in 
5 % CO2 at + 37 oC for 4 to 5 hours. On a glass slide, 5 μl of well-mixed broth culture and 
5 μl of pneumococcal omniserum (Statens Serum Institut, Denmark) were mixed and 
examined immediately under a microscope (40X). Instead of omniserum, 0.9 % NaCl was 
used as a control. In a positive quellung reaction the organisms look light and swollen 
(the capsule becomes visible). The single cocci double or triple in size and agglutinate 
into clumps. In a negative reaction the organisms look like thin cocci in pairs and chains. 
4.3.4. Biochemical identification with API 20 STREP  (III) 
The API 20 STREP system (bioMerieux, Marcy l′Etoile, France), based on the demon-
stration of enzymatic activity or the fermentation of sugars, was applied according to the 
manufacturer’s instructions. Fresh bacterial growth from a blood agar plate was collected 
with a swab and immersed in the API medium and used in reactions. The metabolic end 
production of enzymatic activity comes into view either through spontaneous coloured 
reactions or by addition of reagents. Fermentation of carbohydrates is detected by a shift 
in the pH indicator. The reactions were interpreted after incubation at + 37 oC for 2 hours, 
after which the incubation was continued overnight. The reactions were interpreted ac-
cording to the Reading Table and coded into a numerical profile after final interpretation 
of the reactions. The identification was obtained by comparing the achieved profile with 
the Analytical Profile Index. 
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4.4    Genetechnological identification methods 
4.4.1 Specific nucleic acid probe (AccuProbe¥) (I, II, III)
DNA hybridization was performed using the AccuProbe ¥Streptococcus pneumoniae
culture identification test (GEN-PROBE®, San Diego, CA, USA) according to the manu-
facturer’s instructions. Briefly, five to ten colonies were collected from a fresh blood agar 
plate, suspended in a lysis reagent tube, incubated and a hybridization buffer was added. 
After incubation a selection reagent was added. This reagent differentiated non-
hybridized and hybridized probes, and labelled DNA-RNA hybrids could be measured 
with the Gen-Probe luminometer. The cutoff value of reflective light units (RLU) for a 
positive result was 50,000. 
4.4.2 Conventional ply PCR for detection of pneumococcal pneumolysin (I, II, III)
A polymerase chain reaction, PCR, based on amplification of the ply gene fragment, as 
described originally by Virolainen (Virolainen et al. 1994), was performed in papers I, II 
and III with some modifications (Salo et al. 1995, Rintamäki et al. 2002) (Table 3). 
Briefly, one pneumococcal colony was suspended in 100 μl of PCR reaction mix. The 
primers that were used amplified a 209-bp region of the ply gene (IIa and Biotin labelled 
IIb). Amplification was done and the amplification products were identified using agarose 
gel electrophoresis with ethidium bromide staining and confirmed by solution hybridiza-
tion with a Europium-labelled probe (Rintamäki et al. 2002). 
4.4.3 Detection of the pneumococcal surface antigen A (psaA) gene and the autolysin 
(lytA) gene (II)
To amplify the pneumococcal surface antigen A (psaA) gene and the autolysin (lytA)
gene, DNA from one colony was extracted by alkaline lysis and diluted with distilled 
water. To detect the presence of the psaA gene, the extracted DNA was amplified as de-
signed by Morrison and coworkers (Morrison et al. 2000). The primers that were used 
amplified a part of the psaA gene and the resulting product was a fragment of 838 bp. To 
detect the presence of the lytA gene, the extracted DNA was amplified as designed by 
McAvin and coworkers (McAvin et al. 2001). The primers amplified a 101 bp fragment 
of the lytA gene (Table 3). The presence of amplification products of psaA and lytA was 
checked using electrophoresis on 2% agarose gels stained with ethidium bromide. 
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Primer/probe 
(size of product) 
Sequence Reference 
Conventional 
PCR 
pneumolysin (ply) 
inner primers 
(209- bp) IIa 
IIb 
5´- CCCACTCTTCTTGCGGTTGA-3´ 
5´-TGAGCCGTTATTTTTTCATACTG-3´ 
 (Salo et al.
1995) 
Conventional 
PCR 
ply (209-bp) 
WO 506 
WO 507 
Eu hybridisation 
probe 
5´-biotin-modC)1CCCACTCTTCTTGCGGTTGA-3´ 
5´-TGAGCCGTTATTTTTTCATACTG-3´ 
5´-(Eua-modC)20 GAGAAAGCTATCGCTACT-3´ 
(Rintamäki
et al. 2002) 
Real-time 
PCR 
ply (206-bp)  
(forward) LCIIa, 
(reverse) IIb 
FLU probe 
LC probe 
5´-ACTCTTCTTGCGGTTGATCG-3´ 
5´-TGAGCCGTTATTTTTTCATACTG-3´ 
5´-TCTCCAAGTGGAAGACCCCAGCAA-Flub
LCRed640cc-CAAGTGTTCGCGGAGCGGTAAAC-pd
(Saukkoriipi
et al. 2002) 
Conventional 
PCR 
psaA1 (838-bp) 
psaA2 
 5´-CTTTCTGCAATCATTCTTG-3´ 
5´-GCCTTCTTTACCTTGTTCTGC-3´ 
(Morrison et 
al. 2000) 
Conventional 
PCR 
lytAF (101-bp) 
lytAR 
5´-ACGCAATCTAGCAGATGAAGC-3´ 
5´-TGTTTGGTTGGTTATTCGTGC-3´ 
(McAvin et 
al. 2001) 
Table 3. Primers and probes used in the PCR analyses to detect S. pneumoniae DNA.
a Europium. b Fluorescein. c LightCycler Red640. d Phosphate.
4.4.4 ARDRA (II) 
Amplified rDNA restriction analysis (ARDRA), i.e. amplification of the 16S rRNA gene 
and subsequent restriction digestion with RsaI followed by agarose electrophoresis, was 
carried out as described previously (De Baere et al. 2002). This analysis was carried out 
in the Department of Chemistry, Microbiology and Immunology, Ghent University Hos-
pital, Belgium. 
4.4.5 Real-time pneumolysin PCR (III) 
For a real-time ply PCR, DNA was extracted from fresh growth and a real-time PCR was 
performed as follows. Five α-hemolytic streptococcal colonies were suspended in 100 μl
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of distilled water and boiled. Amplification of a 206-bp fragment of the ply gene was 
performed as described earlier (Saukkoriipi et al. 2002) using the Light Cycler Instrument 
(Roche Diagnostics, Mannheim, Germany) and fluorescence resonance energy transfer 
(FRET) hybridization probes. Fluorescence was measured once after each annealing step. 
4.4.6 Melting curve analysis (III) 
Melting curve analysis was used to confirm the real-time ply results. For melting curve 
analysis, a real-time PCR was performed as described above, but instead of hybridization 
probes and a reaction mixture, a SYBRGreen dye kit (Roche Diagnostics) was used to 
detect the amplification products (Saukkoriipi et al. 2003). The PCR protocol with a few 
modifications was similar to the one described earlier, but continuous fluorescence data 
collection was performed. The fluorescence data gathered during the PCR were analyzed 
using the Second Derivative Maximum method of the Data Analysis program of the 
LightCycler software version 3.5.28 (Roche Diagnostics).  
4.4.7 Sequence analysis (III) 
The purified PCR products were dried and diluted in sterile aqua. Sequencing was per-
formed on both strands using primers LCIIa and IIb. The sequences were assembled by 
using the ContigExpressTM program and aligned by using the AlignX® program, both 
included in the Vector NTI® Suite v.6 (Informax Inc., Bethesda, MD). This analysis was 
carried out by Macrogen (Seoul, South Korea). 
4.5    Survival of bacteria in an STGG medium (IV) 
To test the survival of S. pneumoniae, M. catarrhalis and H. influenzae isolates, STGG 
medium tubes were prepared. STGG tubes containing different amounts of these bacteria 
were prepared for storage at two temperatures, –20oC and –80oC, and subcultures for 
viability testing were performed on blood, blood and gentamicin, and chocolate agar 
plates 18 times during three years. To test the effect of the number of inoculated bacteria 
on the survival of S. pneumoniae, three STGG tubes were prepared for both temperatures 
(–20oC and –80oC) by inoculating them with: (1) five colonies lightly touched with a 1 μl
loop, or (2) 1 μl loopful, or (3) plenty of growth. To test the survival of bacteria in naso-
pharyngeal swabs, 100 consecutive nasopharyngeal swabs in an STGG medium were 
chosen for repeat cultures. After one and a half years of storage at –80 °C, the specimens 
were subcultured and S. pneumoniae, H. influenzae and M. catarrhalis were identified 
and the number of colonies was recorded. The culture results from the original and re-
peated cultures of the nasopharyngeal specimens were compared. 
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4.6     Statistical analysis  
All the variables in paper I were dichotomous (+ or -), and cross-tabulation was used in 
the analysis. Because of the lack of a gold standard, the sensitivity, specificity and posi-
tive and negative predictive values were not included in the analysis. In paper II all the 
variables were dichotomous. In paper III sensitivity and specificity with 95 % confidence 
intervals were calculated using the optochin test as a gold standard. Kappa (ɤ) statistics 
were used to measure the agreement between the optochin test and the other methods. In 
paper IV cross-tabulation was used in the comparison of the culture results from the 
original and stored specimens. 
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5 RESULTS
5.1 Effect of inoculum size on optochin sensitivity and a comparison of different 
optochin discs (I)
The conditions that affect the results of the optochin sensitivity test, i.e. the amount of 
bacteria and different commercial optochin discs, were examined first. In the comparison 
between different inocula in the optochin tests, the light inoculum gave larger diameters 
than the heavy one, but the difference in the diameters was generally small: 0-4 mm in 95 
% and 5-9 mm in 5 % of the strains tested. With the Biodisk product this difference oc-
curred less frequently than with other products. In 23 (5.8 %) of the 400 comparisons, the 
optochin sensitivity results were different with light and heavy inocula. Generally, the 
optochin results were clearly sensitive or resistant. When the heavy inoculum was used, 
the inhibition zones were more clear-cut and measurement was easier. The effect of the 
inoculum was similar with all the optochin discs. 
The comparison of four optochin discs classified by pneumococcal group is presented in 
Table 4. The isolates sensitive to optochin in the Biodisk test included three (6 %) isolates 
resistant according to BBL, seven (14 %) according to Oxoid and one (2 %) according to 
Rosco. On the contrary, the isolates resistant to optochin according to Biodisk included 
one (2 %) isolate sensitive according to BBL and four (8 %) according to Rosco. 
Table 4. Comparison of four optochin discs.
Test disc 
Manufacturer
and result 
Optochin sensitive (+)
Caps+           Caps- 
(N=24)          (N=25) 
Optochin resistant (-)
Caps+           Caps- 
(N=15)          (N=36) 
     
BIODISK  + 24 25 0 0 
                  - 0 0 15 36 
     
BBL          + 23 23 1 0 
                  - 1 2 14 36 
     
OXOID     + 20 22 0 0 
                  - 4 3 15 36 
     
ROSCO    + 23 25 2 2 
                 - 1 0 13 34 
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5.2 Comparison of genetechnological and conventional identification methods (I) 
The isolates were divided into four groups according to their optochin sensitivity and the 
presence of a capsule: typical optochin-sensitive and encapsulated isolates (Opt S, Caps 
+, Group 1), typical optochin-sensitive but unencapsulated isolates (Opt S, Caps -, Group 
2), atypical optochin-resistant, encapsulated isolates (Opt R, Caps +, Group 3), and 
equivocal optochin-resistant and unencapsulated isolates (Opt R, Caps -, Group 4). All 
the typical encapsulated isolates were bile-soluble, positive according to AccuProbe¥ and 
had the ply gene according to the PCR, but discrepancies were seen between the methods 
in the other three groups. Detailed results of the identification tests are presented in Table 
5. Discrepant results in bile solubility and nucleic acid tests were found in 24 % (6/25) of 
Group 2 (Opt S, Caps –), 13 % (2/15) of Group 3 (Opt R, Caps +) and 44 % (16/36) of 
Group 4 (Opt R, Caps -). Of the optochin-sensitive, unencapsulated isolates (Group 2), 92 
% were positive in the AccuProbe¥ test and 100 % in the ply PCR test. Of the atypical 
optochin-resistant but encapsulated isolates (Group 3), 80 % (12/15) were positive in the 
AccuProbe¥ and ply PCR tests, but the results were not identical. In this group, four out 
of five blood isolates were positive in the AccuProbe¥ and ply PCR tests; one was nega-
tive in both tests and weakly positive in the capsular reaction test. Of the equivocal opto-
chin-resistant, unencapsulated isolates (Group 4), 22 % (8/36) were positive in the Accu-
Probe¥ test and 42 % (15/36) in the ply PCR test. The only blood isolate in this group 
was negative according to both nucleic acid methods.  
1) sensitive, 2) resistant, 3) positive capsule reaction, 4) negative capsule reaction, 5) weak capsule reaction 
Table 5. Simultaneous results of the bile test, AccuProbeTM test and ply PCR test in 
four groups of isolates.
 Group N Bile test 
(+/-) 
AccuProbe¥
(N)
ply PCR  
(N)
   + - + -
Optochin S 1) 24 + 24 0 24 01 Capsule + 3)  - 0 0 0 0
Optochin S 25 + 19 0 19 02 Capsule – 4)  - 4 0 4 0
   - 0 2 2 0
Optochin R 2) 15 + 11 0 11 03 Capsule +  + 0 1 1 0
   - 0 25) 0 25)
   - 15) 0 0 1
Optochin R 36 + 2 0 2 04 Capsule -  + 0 4 4 0
   + 0 2 0 2
   - 0 18 0 18
   - 5 0 5 0
   - 0 4 4 0
   - 1 0 0 1
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5.3 Comparison of genetechnological methods in the identification of optochin-
resistant pneumococcus-like isolates (II) 
The reference strains that were used were identified correctly by all phenotypic and ge-
netechnological methods, but the isolates of S. pneumoniae and S. sanguinis had a different 
RsaI restriction pattern compared with the mitis group-specific RsaI ARDRA pattern. 
Among the 49 optochin-resistant pneumococcus-like strains, 11 optochin-resistant but cap-
sulated strains were identified as pneumococci by two phenotypic (bile solubility, the pres-
ence of a capsule) and genetechnological (PCR based on genes of ply, lytA and psaA, Ac-
cuProbe¥ and ARDRA) techniques. Twenty of the 38 optochin-resistant, unencapsulated 
isolates were identified as non-pneumococci by all techniques, but due to the contradicting 
phenotypic and genotypic results, 18 of the 38 optochin-resistant, unencapsulated isolates 
could not be unequivocally identified. AccuProbe¥ and RsaI restriction were always in 
agreement and psaA PCR was always in agreement regarding encapsulation. 
5.4 Comparison of phenotypic and nucleic acid-based methods in the 
identification of nasopharyngeal streptococcal isolates (III) 
Ninety-seven α-hemolytic streptococcal isolates were divided into four groups according 
to their optochin sensitivity and the presence of a capsule for a comparison of the identifi-
cation methods (Table 6). A positive capsular quellung reaction with omniserum was 
originally demonstrated in 59 isolates, but one of them proved to be false positive in later 
analysis. When all of the 65 (Groups 1 and 2) optochin-sensitive isolates were serotyped 
to the type/group level, 64 isolates were shown to have a capsule representing 16 different 
serotypes/groups and one isolate was unencapsulated. Thus, seven discrepancies were 
found between the capsular reactions with omniserum and serotyping. Of the seven om-
niserum-negative isolates (Group 2), however, six were serotypable and only one isolate 
was really unencapsulated and identified as pneumococcus by bile solubility and the Ac-
cuProbe¥, conventional, and real-time ply PCR tests, but as S. mitis by API 20 STREP.
All the optochin-sensitive isolates were bile-soluble, and two of the optochin-resistant 
isolates were also bile-soluble (2/32). The results of identification by API 20 STREP 
showed that 56 of the 97 strains were pneumococci, while 41 were identified as other 
streptococci: 23 S. mitis, 9 S. sanguis, 1 S. salivarius and 2 Gemella morbillorum. Six 
isolates remained without identification of species. 
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Table 6. Results of tube bile solubility, API 20 STREP system, AccuProbe¥, and conven-
tional and real time ply PCR tests in four groups of isolates.
Group N Bile  
solubility 
(+/-)
API 20 
STREP
(+/-)
AccuProbe¥
(+/-)
ply PCR 
(+/-)
Real-time 
ply PCR
(+/-)
1
Optochin S 1)
Capsule + 2)
58 58/0 47/11 58/0 58/0 58/0 
2
Optochin S 
Capsule – 3)
7 7/0 5/2 7/0 7/0 7/0 
3
Optochin R 4)
Capsule + 
1 0/1 0/1 0/1 0/1 0/1 
4
Optochin R 
Capsule –
31 + 2 
–29
0/2 
4/25 
0/2 
1/28 
1/1 
7/22 
0/2 
0/29 
1) sensitive, 2) positive capsule reaction with Pnc omniserum, 3) negative capsule reaction with Pnc 
omniserum, 4) resistant, +: positive/suggestive of Pnc, – : negative/not suggestive of Pnc 
Identification results obtained with AccuProbe¥ and a real-time ply PCR were almost 
identical. AccuProbe¥ identified as pneumococcus one isolate in Group 4 (optochin-
resistant, unencapsulated). The conventional ply PCR method detected the ply gene in all 
65 optochin-sensitive isolates (Groups 1 and 2) and in eight optochin-resistant isolates 
(Group 4). All 65 isolates in Groups 1 and 2 were also positive according to the real-time 
ply PCR, and they had quickly rising amplification curves typical for pneumococcus. The 
only isolate in Group 3 as well as 22 of the 31 optochin-resistant isolates in Group 4 
could not to be amplified at all.  
The sensitivities, specificities, and agreement in κ-values of each test compared with the 
optochin test are found in Table 2 in the original publication. The strength of agreement 
between the optochin test and the other tests, measured by κ-statistics, was ‘very good’, 
except in the case pf API 20 STREP and conventional ply PCR, for which ‘good’ agree-
ment was obtained. 
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5.5 Real-time ply PCR with melting curve analysis differentiates pneumococcus 
from other α-hemolytic streptococci 
Nine isolates in Group 4 (Table 6.) produced some amplification products, but all these 
isolates had exceptionally low amplification curves compared with those of 65 optochin-
sensitive isolates. The amplification curves of these nine isolates were similar to each 
other. In further analysis using a real-time ply PCR combined with melting curve analysis 
of all the amplification products, all nine of these isolates could be amplified in a PCR, 
but a slightly different product melting temperature was seen. A sequence analysis of the 
purified real-time ply PCR products of these nine isolates showed that the sequences 
closely resembled the ply sequence, with the exception that they all contained several 
point mutations in the 206-bp region studied. Three mutations were identical in all the 
isolates, and two of these (GÆA and CÆT) were located at the binding site of one of the 
hybridization probes. Four isolates also had a mutation (CÆT) at the binding site of the 
other probe. The three optochin-sensitive isolates tested for comparison did not contain 
any mutations in the region studied. 
5.6 Survival of S. pneumoniae, H. influenzae and M. catarrhalis in an STGG 
medium (IV) 
S. pneumoniae and M. catarrhalis isolates survived freezing at –80oC and 18 cycles of 
thawing over a period of three years without any change in the number of colonies. The 
number of H. influenzae colonies decreased after 15 months.  The number of colonies of 
all the bacteria decreased at –20oC, and only S. pneumoniae survived the whole study 
period. The number of pneumococci did not effect the survival of the bacteria. Also, in 
the mixture of the three species, S. pneumoniae and M. catarrhalis survived well at –80oC
for three years with 18 cycles and H. influenzae, with a decreased number of colonies, for 
up to two years. The number of colonies decreased earlier at –20oC than at –80oC, and 
only M. catarrhalis survived the whole study period. Table 7. shows the growth of S.
pneumoniae, H. influenzae and M. catarrhalis in nasopharyngeal swabs in an STGG me-
dium cultured after one and a half years of storage at –80oC, compared with the original 
cultures. The results of the repeat and original cultures were almost identical. 
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Table 7. Growth of S. pneumoniae, H. influenzae, and M. catarrhalis from 100 NP swabs 
in an STGG medium cultured after storage at – 80°C for 1.5 years compared with origi-
nal cultures.
Number of NP swabs with n colonies after storage Original number of 
colonies
0 <100 >100 Total 
S. pneumoniae     
0 68 1  69 
<100  8 3 11 
>100   20 20 
Total 68 9 23 100 
H. influenzae     
0 91 1  92 
 <100 1 3  4 
>100   4 4 
Total 92 4 4 100 
M. catarrhalis     
0 62 1  63 
 <100 2 8  10 
>100  4 23 27 
Total 64 13 23 100 
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6 DISCUSSION 
The results of the present study show that the optochin sensitivity test is still a reliable 
and practical test for identifying pneumococcus from invasive as well as respiratory tract 
infections, and even from nasopharyngeal specimens that may contain high numbers of α-
hemolytic streptococci. Nucleic acid methods such as the PCR method, based on amplifi-
cation of the genes (ply, psaA, lytA) that encode pneumococcal virulence factors, and 
methods based on the detection of the 16S rRNA gene (AccuProbe ¥Streptococcus 
pneumoniae, ARDRA) provide new possibilities for pneumococcal identification. How-
ever, the results of this study further show that these methods may misidentify as pneu-
mococcus also those closely related streptococci that harbour elements of pneumococcal 
genes. The ply gene that is most commonly used in the detection of pneumococcus by 
means of PCR methods continues to be a suitable gene for identifying pneumococcus, 
since the real-time ply PCR confirmed by melting curve analysis can be used to exclude 
false positive ply PCR results.
Our study material included isolates that were optochin-sensitive, capsulated or unencap-
sulated and optochin-resistant, capsulated or unencapsulated isolates (in paper I and II). 
Thus, the study material contained a large proportion of difficult isolates sent to the refer-
ence laboratory for identification and serotyping, and does not represent typical isolates 
of either a clinical bacteriologic laboratory or a reference laboratory, and discrepant test 
results are therefore common in this study. The reason for this kind of selection was the 
need to test the methods used to identify “difficult” untypical pneumococci. The study 
material in paper III represents common nasopharyngeal isolates, although the proportion 
of capsulated isolates was higher than usual. However, a real-time ply PCR with melting 
curve analysis proved to be useful in differentiating pneumococcus from other α-
hemolytic streptococci, and the method might be especially useful in certain circum-
stances like pneumococcal conjugate vaccine studies when very accurate pneumococcal 
identification is needed. 
6.1 Conventional, phenotypic identification methods 
According to our earlier experience in the bacteriological laboratory, the density of an 
inoculum (number of colonies) and the optochin discs that are used may influence the 
optochin sensitivity test result. Therefore, the conditions (inoculum, different commercial 
products) of the optochin test were investigated carefully to obtain a firm basis for the 
following classification of isolates according to optochin sensitivity. Wasilauskas and 
Hampton (Wasilauskas & Hampton 1984) have presented that inadequate numbers of 
colonies may lead to an erroneous result in optochin sensitivity, whereas our results sug-
gest that the density of colonies has only a small effect on the result of the optochin sensi-
tivity test. However, when a heavy inoculum is used, the diameter of the optochin sensi-
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tivity test is smaller than when a light inoculum is used, and in borderline cases the result 
of the optochin sensitivity test should be interpreted as sensitive or the test should be re-
peated. When this study started there were at least four commercial manufacturers of 
optochin discs. In our experience the Biodisk disc seemed to be more reliable than the 
other products, and it was not too sensitive to the effect of inoculum size.  
Although identification tests based on phenotypic characteristics of pneumococcus are 
reliable and commonly used to identify pneumococcus (Mundy et al. 1998, Ruoff et al.
2003), some identification problems exist. Optochin-resistant pneumococcal isolates were 
found already in the early days (see White 1938, Bowers & Jeffries 1955) as well as more 
recently (Kontiainen & Sivonen 1987, Pikis et al. 2001), unpublished data from the refer-
ence laboratory for pneumococcus). It is also well known that some typical pneumococci 
are unencapsulated (Finland & Barnes 1977, Broome & Facklam 1981, Carvalho et al.
2003), and on the other hand, several α-hemolytic streptococci (Austrian 1976, Holmberg
et al. 1985) as well other bacteria (Zepp & Hodes 1943, Robbins et al. 1972, Heidelber-
ger & Nimmich 1972) produce capsules which cross-react with S. pneumoniae serotypes 
(Lund & Henrichsen 1978). The quellung reaction, the most reliable method for demon-
strating the capsule, is not commonly used in clinical bacteriological laboratories. Inter-
pretation of the capsule reaction requires considerable experience, as also seen in our 
laboratory: three positive but weak reactions (3/100) were probably misinterpreted (paper 
I, II), and seven discrepancies were found between the capsular reactions with pneumo-
coccal omniserum and actual pneumococcal serotyping (paper III).  
Bile solubility and optochin sensitivity have shown to have almost complete correlation 
(Bowers & Jeffries 1955), but in 10 % of cases the interpretation was considered uncer-
tain (Lund 1959).  In our study (paper II), bile solubility results obtained in two laborato-
ries were not similar, and therefore only the results of the reference laboratory were pre-
sented. The results of the present study suggest that bile solubility is a useful confirma-
tory test, but it could not be used as the only method to differentiate pneumococcus from 
other streptococci. However, Arbique and coworkers (Arbique et al. 2004) suggest that 
the bile solubility test differentiates pneumococcus from S. pseudopneumoniae (optochin-
resistant, unencapsulated, bile-insoluble, AccuProbe¥-positive and ply and sodA-positive
PCR) and that bile solubility is more specific than optochin sensitivity in identifying 
pneumococcus. 
Biochemical identification of pneumococcus has been proved to be quite difficult, and 
additional tests such as optochin sensitivity were recommended (Colman & Ball 1984, 
Appelbaum et al. 1986). If two bacterial strains carry the same enzymic activities, it is 
difficult to say whether they produce exactly the same enzyme molecules or whether they 
produce similar enzymic activities produced by different molecules (Norris 1968). In the 
latter situation there is no direct relationship at the genetic level. Many strains that were 
identified biochemically as S. mitis were found to be difficult to differentiate from S. or-
alis and S. pneumoniae, even with the quantitative DNA-DNA hybridization method, 
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because clinical strains strongly hybridized with both S. mitis and S. oralis and sometimes 
S. pneumoniae (Kawamura et al. 1995). These three species have more than 99 % se-
quence homology with each other, and thus they are closely related (Kawamura et al.
1995). In our first study (paper I), no biochemical tests were used in the characterization 
of the isolates, and no further classification of ”nonpneumococcal” isolates could thus be 
given. Later, in paper III, we defined bacterial isolates also biochemically, and these re-
sults confirm our earlier experience that biochemical tests are not very useful in differen-
tiating pneumococcus from other α-hemolytic streptococci. 
6.2 Nucleic acid methods 
The hybridization test, AccuProbe¥ for pneumococcus, has been used and suggested as a 
”gold standard” for identifying pneumococcus (Denys & Carey 1992, Geslin et al. 1997, 
Mundy et al. 1998). Later studies have shown, however, that identification or definition 
of pneumococcus is a more complicated issue (Whatmore et al. 2000, Arbique et al. 2004, 
Hanage et al. 2005). The main results of our study are in agreement with those of Mundy 
and coworkers (Mundy et al. 1998) and Whatmore and coworkers (Whatmore et al. 
2000). In our study, AccuProbe¥ for pneumococcus correctly identified unequivocal 
pneumococci (optochin-sensitive, bile-soluble, quellung reaction-positive), but not all 
optochin-sensitive, unencapsulated isolates. Moreover, the results of Mundy as well our 
results show discrepancies among equivocal isolates (inconsistent or discordant combina-
tions of optochin sensitivity, bile solubility and quellung reaction positivity). Mundy pre-
sented that almost 30 % were positive in the AccuProbe¥ test, but only less than 3 % in 
the quellung reaction, and ten of the AccuProbe¥ positive isolates had an intermediate 
optochin result as their only phenotypic characteristic. In our study, AccuProbe¥ identi-
fied as pneumococci some optochin-resistant, unencapsulated isolates (papers I, II) as 
well as one optochin-resistant, unencapsulated, bile-insoluble isolate, which was identi-
fied biochemically as S. mitis (paper III). It is possible that these isolates represent a new 
streptococcal species such as S. pseudopneumoniae (Arbique et al. 2004). Although Ac-
cuProbe¥ and RsaI digestion of the 16S rRNA gene appear to enable identification of all 
genuine S. pneumoniae isolates, they cannot exclude closely related nonpneumococcal S.
mitis strains that have (nearly) identical 16S rRNA genes, resulting in “false positive” 
AccuProbe¥ and ARDRA results.  
The primers described by Morrison and coworkers (Morrison et al. 2000) that enabled 
amplification of the psaA gene from all 90 serotypes of S. pneumoniae and were used in 
this study appear to be very S. pneumoniae-specific. Only genuine pneumococci and the 
optochin-resistant but capsulated pneumococci gave amplification of psaA (see Table 1.  
in paper II). This psaA PCR positivity was always in agreement with capsulation. The 
specificity of the lytA PCR was high as well. AccuProbe¥ and ARDRA were considered 
to be somewhat less specific, but these approaches largely coincided with the presence of 
pneumococcal virulence genes and therefore retain their value.  
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Demonstration of Ply (Cima-Cabal et al. 1999) or the ply gene (Salo et al. 1995, Kearns
et al. 2000) have been used as methods for detecting and identifying pneumococcus. In 
these studies, the presence of ply has been suggested to be specific for pneumococcus. 
However, in addition to typical optochin-sensitive, bile-soluble, capsulated pneumococci, 
these methods have also identified the ply gene in atypical pneumococci (Cima-Cabal et 
al. 1999, Kearns et al. 2000). Moreover, even other α-hemolytic streptococci and atypical 
”pneumococcus-like” bacteria sometimes had the ply gene (Whatmore et al. 2000). Our 
results (papers I, II and III) show that some isolates without any other characteristics of 
pneumococcus contained the ply gene in the conventional ply PCR test. However, the 
real-time ply PCR with melting curve analysis developed in our laboratory proved to be a 
specific method in discriminating the ply gene of pneumococcus from those in other α-
hemolytic streptococci: the real-time ply PCR with melting curve analysis was able to 
exclude false positive ply findings, since isolates containing as few as two mutations in 
the target ply sequence of the probes produced aberrant amplification curves (paper III). 
6.3 Storage and transport medium for pneumococcus 
As both identification of problematic isolates and serotyping of pneumococci are usually 
done in specialized laboratories, the survival of three nasopharyngeal pathogens during 
storage and transport was also studied. Our results confirm and extend the findings of 
O’Brien and coworkers (O'Brien et al. 2001) by demonstrating that an STGG medium is 
excellent for deep-freeze storage of S. pneumoniae, H. influenzae and M. catarrhalis for 
long periods. It can also be used for storage at –20oC for shorter periods, even in condi-
tions with a less than ideal electricity supply. The use of an STGG medium has several 
benefits, including enhanced recovery, long-term storage of original NP specimens at –
70oC without any loss of CFU, and the possibility of testing NP specimens as batches. On 
the basis of the present study results, we fully agree with the conclusions of O’Brien and 
coworkers (O'Brien et al. 2001) on the usefulness of an STGG medium in the storage and 
transport of pneumococcus, extending them further to two other respiratory tract patho-
gens, H. influenzae and M. catarrhalis. Moreover, our observations over several years 
indicate that bacterial isolates stay viable in an STGG medium longer than the three stud-
ied years shown, and that an STGG medium is also suitable for transporting the isolates 
(Herva et al. 2006).  
6.4 What is pneumococcus – does it need to be redefined? 
On the basis of phenotypic identification methods, pneumococcus has been and still is 
defined as an optochin-sensitive, bile-soluble, usually encapsulated α-hemolytic strepto-
coccus. In a Gram stain it appears as gram-positive diplococci that sometimes form short 
chains. Colony morphology on blood agar is typically smooth, glistening and doughnut-
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like. With these conventional criteria, most pneumococcal isolates, especially when from 
blood or cerebrospinal fluid, can easily and reliably be identified and discriminated from 
other α-hemolytic streptococci that are generally considered to be less pathogenic and 
virulent than pneumococcus. 
As a result of common genetic transformation - the exchanges of virulence factors among 
streptococcal species - untypical pneumococci and new, closely related streptococcal 
species such as S. sinensis (Woo et al. 2002) and S. pseudopneumoniae (Arbique et al.
2004) have emerged and led to problems in pneumococcal identification and, accord-
ingly, to the development of molecular microbiological methods of identification. At least 
three main molecular approaches have been applied: 1) identification of pneumococcus 
by hybridization with a gene probe based on the 16S rRNA sequence, 2) identification of 
pneumococcus (actually pneumococcal clones) by sequencing housekeeping genes 
(MLST) and 3) demonstration of genes for pneumococcal virulence factors, such as ply,
psaA and lytA. The question is: can these new molecular methods provide us with new 
definitions for pneumococcus? 
Although a commercial gene probe test for identifying pneumococcus (AccuProbe¥) on 
the basis of the 16S rRNA gene seems to enable identification of all genuine S. pneumo-
niae isolates, it cannot exclude closely related nonpneumococcal S. mitis or other strepto-
coccal strains that have (nearly) identical 16S rRNA genes, resulting in “false positive” 
AccuProbe¥ results. In these cases, conventional identification tests might be helpful. 
However, in the present study, AccuProbe¥ misidentified several “difficult” atypical 
strains as pneumococcus. MLST, a rather time-consuming, complicated and expensive 
method can, in certain cases, be applied to confirm pneumococcal identification, even 
though it is most useful for identifying pneumococcal clones. Complete resolution of 
pneumococci from the sometimes closely related α-hemolytic streptococci is problematic 
due to recombination between them. However, a tree based on the concatenated se-
quences of the MLST loci in most cases unambiguously distinguishes whether an unen-
capsulated or otherwise atypical isolate is or is not a pneumococcus (Hanage et al. 2005).  
Demonstration of the genes of pneumococcal virulence factors such as psaA, lytA and ply
(Salo et al. 1995, Morrison et al. 2000, McAvin et al. 2001), e.g. by using a PCR, has 
been suggested to be helpful in identification. Several recent studies have, however, 
shown that these virulence factors can also be found in α-hemolytic streptococci and, 
thus, the presence of these genes cannot be used as the sole method for identifying pneu-
mococcus. Luckily enough, both the lytA and ply genes, when present in α-hemolytic 
streptococci, seem to have mutations and can on this basis be distinguished from pneu-
mococci: we showed in the present study that the melting points of the amplification 
products of the ply gene are different in α-hemolytic streptococci and pneumococcus due 
to minor mutations in the ply gene. Additionally, Llull and coworkers (Llull et al. 2006) 
recently showed that all the S. pneumoniae strains they tested harboured typical lytA al-
leles, whereas nonpneumococcal isolates belonging e.g. to the mitis group always carried 
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atypical alleles. However, further studies are needed to determine if these mutations are 
exclusively seen only in α-hemolytic streptococci. 
Due to the common transfer of genetic material between pneumococcus and α-hemolytic 
streptococci, it is possible that no single perfect method for pneumococcal identification 
can be developed. In the case of equivocal pneumococci, molecular methods may help in 
identification, but in certain cases definite identification may still be missed.  
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7 CONCLUSIONS 
The reason for starting this study was the practical need to solve the identification prob-
lem concerning some of the isolates that were sent to the National Reference Laboratory 
for Pneumococcus (National Public Health Institute, Oulu). Identification of suspected 
pneumococcal isolates lacking one or more of the typical characteristics of pneumococcus 
was found to be problematic. Carefully performed, the optochin sensitivity test is still the 
basic method used to differentiate pneumococcus from other α-hemolytic streptococci, 
even among nasopharyngeal pneumococcal isolates. Other phenotypic identification tests 
- the detection of a capsule and bile solubility - can be used as confirmation methods. 
Genetechnological methods, for example based on the demonstration of pneumococcal 
genes, provide new possibilities for identifying S. pneumoniae, but their use may lead to 
misidentification of too many α-hemolytic streptococci as pneumococcus. The present 
study suggests that a real-time ply PCR with melting curve analysis, which discriminates 
ply genes with mutations, can be used to exclude false positive ply PCR findings among 
α-hemolytic streptococci. On the basis of this study, the following flow chart for identifi-
cation is recommended (Fig. 8). 
The identification of Streptococcus pneumoniae 
Fig. 8. Flow chart for the identification of pneumococcus
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